https://www.dailyhealthindustry.it/farmaci-25-test-in-italia-riguardano-le-malattie-rare/ 2016-03-30T09:40:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-scaccabarozzi-lema-venga-in-italia/ 2016-03-30T09:18:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ddl-concorrenza-ok-vendita-farmaci-con-bugiardino-vecchio-aggiornato-online/ 2016-03-30T09:17:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-gelli-pd-1-200-introvabili-aifa-riferisca/ 2016-03-30T09:16:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-lancia-il-progetto-prime-piu-veloce-approvazione-farmaci-promettenti/ 2016-04-05T10:38:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-de-vincenti-errore-unico-tetto-spesa/ 2016-03-30T09:15:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/polpastrelli-bionici-restituiscono-sensibilita-agli-amputati/ 2016-04-28T15:43:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-pensa-al-dopo-humira-e-investe-595-milioni-di-dollari-su-nuovo-antipsoriasi/ 2016-03-30T09:39:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-e-lundbeck-lanciano-rexulti-negi-usa-a-colpi-di-spot/ 2016-03-30T09:13:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/data-managment-non-se-ma-quando/ 2016-04-28T15:53:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/social-media-e-big-pharma-interessanti-novita-da-instagram/ 2016-04-28T15:49:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-lancia-studio-sui-danni-cerebrali-per-un-nuovo-protocollo-diagnostico/ 2020-11-10T08:45:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/con-connectivity-bridge-google-punta-sempre-di-piu-sullhealthcare/ 2016-04-28T15:44:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-pensa-di-chiudere-quartier-generale-di-covidien-e-punta-sul-lavoro-in-remoto/ 2016-04-28T15:43:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-e-gilead-e-scontro-sul-brevetto-di-sofosbuvir/ 2016-03-30T09:08:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/baxalta-si-defila-dal-trial-in-fase-3-dellantitumorale-di-onconova/ 2020-11-10T08:45:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/patient-data-una-interessante-soluzione-per-privacy-e-profilazione/ 2020-11-10T08:24:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-cosa-pensa-amgen-per-il-rilancio/ 2020-11-10T08:45:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-caso-actos-le-precisazioni-aifa/ 2020-11-10T08:45:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pani-a-guida-informatizzazione-agenzie-regolatorie/ 2016-03-30T09:03:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sale-la-reputazione-del-pharma-tra-i-pazienti-ecco-la-classifica-delle-piu-apprezzate/ 2016-04-28T15:59:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/stelara-efficace-anche-nella-malattia-di-crohn/ 2020-11-10T08:45:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/quanto-costera-a-bigpharma-il-taglio-degli-annunci-pubblicitari-previsto-da-google/ 2016-04-28T15:52:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/xeljanz-pfizer-efficace-su-sintomi-e-remissione-nella-colite-ulcerosa/ 2020-11-10T08:45:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/e-mail-marketing-la-forza-dei-contenuti-dinamici/ 2016-04-28T15:54:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-in-usa-app-simil-groupon-per-farmaci-costosi-scontati/ 2016-03-30T09:36:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/accesso-5-sfide-per-i-biologici/ 2016-03-30T08:53:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/twitter-facebook-e-google-studiano-come-avvicinare-il-pharma/ 2016-04-28T15:48:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-farmaceutici-a-caccia-di-farmaci-biologici-in-area-respiratorio-sale-il-fatturato-del-94/ 2016-04-01T08:57:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/opinione-positiva-del-chmp-per-terapia-genica-contro-ada-scid-di-gsk/ 2016-04-01T17:34:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-nel-2015-autorizzati-39-nuovi-farmaci-e-54-estensioni-di-indicazione/ 2020-11-10T08:45:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattia-di-fabry-migalastat-ha-ricevuto-parere-positivo-dellue/ 2020-11-10T08:45:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-su-siti-web-per-la-salute-usability-batte-affidabilita-i-millennials-i-piu-recettivi-alla-pubblicita/ 2016-04-28T15:51:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/colesterolo-per-esperti-occorre-trovare-nuovi-metodi-di-controllo-dopo-i-fallimenti-degli-ultimi-anni/ 2020-11-10T08:45:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mieloma-multiplo-ok-condizionato-a-darzalex-per-reuters-fatturera-oltre-2-mld-entro-il-2020/ 2020-11-10T08:45:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-riparte-la-corsa-per-incrementare-le-vendite-di-ticagrelor/ 2016-04-07T06:56:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-in-usa-costi-insulina-piu-che-raddoppiati-tra-il-2002-e-il-2013/ 2016-04-07T06:53:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-e-sanofi-per-dupilumab-obiettivo-5-miliardi-di-dollari/ 2016-04-07T06:51:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valore-del-brand-per-interbrand-pfizer-roche-e-merck-sono-i-magnifici-tre/ 2016-04-07T06:50:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-fda-propone-etichette-simili-a-quelle-dei-generici/ 2016-04-07T14:54:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/reazione-crociata-tra-anticorpi-di-remicade-e-dei-suoi-biosimilari-a-rischio-lo-switch-lallarme-dei-ricercatori/ 2020-11-10T08:45:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-allergan-salta-laccordo-da-160-miliardi-di-dollari/ 2016-04-28T16:05:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-in-usa-respinte-le-cause-contro-zoloft/ 2016-04-28T16:06:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mieloma-multiplo-pronto-un-dossier-comparativo-di-icer-critiche-da-amgen/ 2016-04-07T15:15:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-da-studi-su-adulti-la-previsione-delleffetto-dei-farmaci-sui-bambini/ 2020-11-10T08:45:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-perde-il-ricorso-consiglio-stato-sancisce-il-principio-dellequivalenza-terapeutica-tra-due-farmaci-diversi/ 2016-04-07T15:20:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-fiducia-al-ceo-dopo-mancata-fusione-con-allergan/ 2016-05-03T07:50:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-ok-da-fda-per-primo-pacemaker-wireless/ 2016-04-08T12:14:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-uk-collaborazione-con-nhs-per-rimborso-anti-tumorali/ 2016-04-28T16:26:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giro-dorizzonte-la-settimana-nel-mondo-farmaceutico/ 2016-04-08T15:03:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-dal-30-giugno-online-nomi-e-collaborazioni-dei-medici/ 2016-04-11T08:33:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-si-al-primo-farmaco-stampato-in-3d/ 2016-04-11T08:43:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-e-roche-fda-approva-venetoclax-per-leucemia-linfatica-cronica/ 2016-04-12T14:11:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oxford-biotherapeutics-e-nerviano-medical-sciences-accordo-per-sviluppo-antitumorali/ 2020-11-10T08:45:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rapporto-icer-nuovi-farmaci-per-mieloma-tutti-troppo-costosi/ 2016-05-03T07:55:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/clovis-oncology-no-da-panel-di-esperti-per-approvazione-accelerata-di-rociletinib/ 2016-04-13T15:59:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-fino-a-6-miliardi-di-dollari-se-vende-portfolio-emofilia/ 2016-04-28T16:28:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-fda-esamina-nuovo-farmaco-contro-acaro-della-polvere/ 2016-04-14T11:38:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-ideatore-napster-fonda-il-parker-institute-for-cancer-immunotherapy/ 2016-04-14T11:50:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/think-thank-creativi-big-pharma-racconti-storie-semplici-che-parlino-delle-origini/ 2016-04-28T16:29:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-nel-2020-spesa-farmaceutica-a-400-miliardi-di-dollari/ 2016-04-15T08:38:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-29-principi-attivi-perderanno-il-brevetto-nel-2016/ 2016-05-03T08:35:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/report-ims-aumento-della-spesa-determinato-dai-nuovi-farmaci/ 2016-04-28T16:15:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-via-alle-procedure-per-lestensione-di-keytruda-e-opdivo/ 2020-11-10T19:28:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-la-leva-e-nei-servizi-al-paziente-in-forma-digitale/ 2016-05-03T07:52:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-biologici-la-cina-investe-in-germania/ 2016-04-28T16:15:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-breakthrough-therapy-passo-avanti-o-vera-rivoluzione/ 2016-04-18T15:48:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-fda-estende-gilotrif-a-carcinoma-polmonare-a-cellule-squamose/ 2016-04-28T16:30:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-il-futuro-e-nei-vaccini/ 2016-04-28T07:54:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/web-in-salute-una-bussola-2-0-per-medici-pazienti-e-farmacisti/ 2016-05-03T08:27:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/acquisizioni-baxter-e-advent-in-gara-per-lindiana-gland-pharma/ 2016-04-28T16:31:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharmachem-e-gilead-si-rafforza-il-legame-con-sito-produttivo-alle-bahamas/ 2016-04-28T07:54:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-bene-il-q1-superate-le-previsioni-degli-analisti-ma-calano-le-vendite/ 2016-04-28T16:33:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-investe-ancora-nellimmunoncologia-nuovo-impianto-rs-in-california/ 2016-04-28T16:33:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cina-tre-aziende-indagate-per-presunta-contraffazione/ 2016-04-28T07:52:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/webmd-e-medscape-puntano-su-mobile-e-video/ 2016-05-03T08:27:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-q1-in-calo-per-genericazione-gleevec/ 2016-04-28T16:34:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-obiettivo-neuroscienze-nuovo-accordo-con-universita-di-la-jolla/ 2020-11-10T08:45:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-accordo-con-argenx-per-sviluppo-immunoncologia/ 2016-04-28T16:35:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/arruolare-i-pazienti-per-un-trial-clinico-ora-si-fa-online/ 2016-05-03T08:27:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/8-regole-per-sfruttare-il-digitale-nel-pharma/ 2016-05-03T08:26:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-approvate-regole-per-audizioni-dei-pazienti/ 2016-04-22T07:35:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-studia-un-antibiotico-basilea-pharmaceutica-lavora-con-fda/ 2020-11-10T08:45:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-bene-il-q1-ma-si-cercano-sinergie/ 2016-04-23T10:26:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-shopping-nella-medicina-estetica-85-mln-di-euro-per-un-agente-topico/ 2016-04-28T16:36:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/st-jude-medical-su-le-vendite-nel-q1-ma-soffre-il-cardiovascolare/ 2016-04-28T16:37:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/apple-rivoluziona-i-trials-clinici-100mila-pazienti-arruolati-via-iphone/ 2016-05-03T08:37:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/adv-e-comunicazione-aziende-farmaceutiche-sempre-piu-social-ma-con-cautela/ 2016-04-28T16:37:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/principi-attivi-2013-2023-lanalisi-di-reportlinker/ 2016-04-28T16:38:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-vicina-la-vendita-delle-azioni-roche/ 2016-04-28T16:39:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-roche-e-pfizer-investono-42-mln-di-dollari-nel-microbioma/ 2020-11-10T08:45:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-da-ironwood-265-mln-di-dollari-per-diritti-usa-zurampic/ 2016-04-28T07:44:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-cessione-generici-a-teva-entro-giugno/ 2020-11-10T19:28:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-asse-usa-cina-per-medicina-dellinvecchiamento/ 2020-11-10T08:45:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-14-confezione-a-testa-nel-2015/ 2016-04-28T08:14:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nokia-punta-su-sanita-digitale-compra-francese-withings/ 2016-04-28T08:25:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-usa-accordo-con-dipartimento-di-giustizia-per-causa-wyeth-medicaid/ 2016-04-28T15:09:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaceutica-italiana-secondo-globaldata-126-da-qui-al-2020/ 2016-05-03T08:23:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/india-nasce-nuovo-centro-per-le-biotecnologie/ 2020-11-10T08:45:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-eps-al-di-sotto-delle-previsioni-nel-q1-bene-i-farmaci-per-il-diabete/ 2020-11-10T08:45:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-genzyme-al-via-contest-europeo-per-pazienti-e-startupper/ 2016-04-28T16:50:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-ok-a-quest-diagnostics-per-i-test-virus-zika/ 2016-05-02T07:03:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ogni-italiano-spende-500-euro-lanno-in-farmaci/ 2016-04-29T07:10:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/apple-arrivano-prime-app-per-la-salute-di-carekit/ 2016-04-29T07:15:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/le-dieci-migliori-pharma-sui-social-media/ 2016-05-03T08:27:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-rinuncia-allacquisto-di-medivation/ 2016-04-29T14:08:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-bene-il-q1-grazie-ai-vaccini-obiettivo-2020/ 2016-04-29T14:18:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-medici-abbott-acquisisce-st-jude-medical/ 2020-11-10T08:44:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/microsoft-da-twist-bioscience-10-mln-di-filamenti-di-dna-artificiale/ 2016-04-29T14:35:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/stryker-negli-usa-al-via-jointcoach-programma-value-based/ 2016-05-04T17:31:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-italia-pronta-alla-rivoluzione-industriale-4-0/ 2016-05-02T10:42:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-e-abbvie-ema-approva-zinbryta-per-sclerosi-multipla/ 2020-11-10T08:44:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-in-cina-q1-con-vendite-a-28/ 2016-05-03T12:47:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-in-arrivo-45-ad-alto-impatto-cure-e-7-000-in-sviluppo/ 2016-05-04T17:14:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anche-in-germania-verso-stretta-sul-prezzo-dei-nuovi-farmaci/ 2016-05-03T12:44:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dnanexus-accordo-con-stanford-per-dati-su-cloud/ 2016-05-03T14:56:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-dei-farmaci-la-francia-porta-la-questione-al-g7/ 2016-05-03T14:56:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/top-five-farmaci-xarelto-di-bayer-leader-in-europa-fino-al-2022/ 2016-05-03T15:52:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ims-health-e-quintiles-fusione-per-9-miliardi-di-dollari/ 2016-05-03T16:25:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ecco-i-20-farmaci-piu-venduti-nel-2020/ 2016-05-04T17:03:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-festeggia-40-anni-in-italia-e-lancia-una-web-serie-su-innovazione-e-salute/ 2016-05-04T17:29:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-medivation-verso-un-possibile-acquisto/ 2016-05-04T17:26:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-una-spin-off-gestira-il-settore-emofilia/ 2016-05-06T14:06:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/contraccezione-la-pillola-domina-il-mercato-mondiale/ 2016-05-04T17:10:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-q1-bene-le-vendite-forecast-positivo/ 2016-05-04T17:41:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/whatsapp-conquista-i-medici-famiglia-la-meta-lo-usa-con-pazienti/ 2016-05-05T09:19:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bpco-arriva-triplice-terapia-per-i-pazienti-piu-gravi-targata-gsk/ 2016-05-05T10:41:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-cresce-il-settore-vaccini-82-nel-q1/ 2016-05-05T13:04:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-tre-offerte-per-cessione-ramo-di-hospira/ 2016-05-05T13:24:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-da-fda-priority-review-per-olaratumab/ 2020-11-10T08:44:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbottst-jude-medical-la-fusione-potrebbe-favorire-un-terzo-player/ 2016-05-05T15:02:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/le-regioni-rivoluzionano-la-governance-del-farmaco/ 2016-05-05T20:49:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/blips-come-trasformare-il-proprio-telefono-in-microscopio/ 2016-05-06T07:50:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sid-no-a-sostituzione-glucometri-nelle-regioni/ 2016-05-06T16:32:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-save-the-children-ema-raccomanda-gel-antisettico-nato-da-partnership/ 2016-05-06T10:50:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-kyprolis-vende-meno-del-previsto-ma-non-perde-quote-di-mercato/ 2016-05-06T11:07:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-altri-250-mln-di-dollari-a-galapagos-per-terapia-fibrosi-cistica/ 2016-05-06T16:32:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-106-mln-di-dollari-per-farmaco-in-fase-pre-clinica-ad-azienda-cinese/ 2020-11-10T08:44:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/device-arriva-il-memristor-e-fatto-di-albumina-tungsteno-e-magnesio/ 2016-05-06T12:50:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-ideaya-biosciences-lavorera-nellimmunoncologia/ 2016-05-06T16:30:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-roche-lancia-una-divisione-dedicata/ 2016-05-09T08:38:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-vendite-deludenti-per-januvia-e-remicade-bene-keytruda/ 2016-05-09T08:50:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/greco-abbvie-necessario-poter-contare-su-regole-certe-e-omogenee/ 2016-05-09T17:51:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/i-primi-risultati-delloperazione-alfasigma/ 2016-05-09T09:41:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-amgen-ottengono-raccomandazione-nice-per-praulent-e-repatha/ 2016-05-09T17:09:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valeant-pronto-un-comitato-interno-per-sorveglaire-sui-prezzi-dei-farmaci/ 2016-05-09T11:20:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mieloma-multiplo-secondo-icer-farmaci-troppo-cari-ma-e-polemica/ 2016-05-10T10:05:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-colpo-da-800-milioni-di-dollari-negli-usa/ 2016-05-09T20:03:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/golimumab-jansenn-efficace-come-terapia-di-mantenimento-per-la-colite-ulcerosa-attiva/ 2020-11-10T08:44:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gates-foundation-38-milioni-di-dollari-a-takeda-per-vaccino-antipolio/ 2016-05-10T09:57:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/migliorano-le-previsioni-di-vendita-per-eylea/ 2016-05-10T10:02:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-problemi-per-il-lancio-di-zepatier-in-europa/ 2020-11-10T08:44:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incyte-sbarca-in-europa-accordo-con-ariad-per-140-milioni-di-dollari/ 2016-05-10T12:31:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-generici-dal-2010-risparmi-potenziali-per-25-miliardi-di-dollari/ 2016-05-12T15:17:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-fusioni-e-acquisizioni-nei-prossimi-5-anni/ 2016-05-10T15:37:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-per-industria-farmaceutica-britannica-ritardi-nellarrivo-dei-nuovi-farmaci/ 2016-05-10T15:36:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-ricerca-e-informazione-corretta-per-combattere-i-superbatteri/ 2016-05-10T15:57:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/le-news-di-reuters-health-ora-anche-in-lingua-italiana-al-via-la-syndication-tra-sics-edizioni-health-communication/ 2016-05-12T16:41:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-profitti-superiori-alle-attese-via-al-buy-back/ 2016-05-11T17:48:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daichii-sankyo-18-mln-di-dollari-a-cell-therapy-per-terapia-con-staminali/ 2020-11-10T08:44:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alzheimer-da-partner-di-genetech-435-mln-di-dollari-per-rd/ 2020-11-10T08:44:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-governo-indiano-approva-brevetto-sovaldi/ 2020-11-10T08:44:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/federfarma-nel-2015-mercato-italiano-a-132-vale-24-miliardi-di-euro/ 2016-05-11T17:13:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/digital-communication-nella-top-ten-bayer-gsk-novo-nordisk-e-roche/ 2016-05-12T14:53:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-politiche-regolatorie-uniformi-call-for-action-ai-g20/ 2016-05-12T15:17:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/universita-di-oxford-da-spin-off-10-mln-di-sterline-per-vaccino-influenza/ 2016-05-12T13:58:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-nel-q1-vendite-vaccini-flat/ 2016-05-12T16:28:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jlabstoronto-apre-il-primo-laboratorio-start-up-jj-fuori-da-usa/ 2016-05-12T13:54:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-nintedanib-rimborsabile-anche-in-italia/ 2016-05-12T14:14:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-si-a-rimborsabilita-atazanavircobicistat-per-hiv-1/ 2016-05-12T16:26:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-negli-usa-selumetinib-farmaco-orfano-per-cancro-alla-tiroide/ 2020-11-10T08:44:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/federfarma-proposte-delle-regioni-inadeguate/ 2016-05-12T17:57:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumori-427-giorni-per-accedere-ai-farmaci-innovativi-in-italia/ 2016-05-13T10:24:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-pmi-motore-dellinnovazione-nel-pharma-europeo/ 2016-05-13T10:46:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/istituto-mario-negri-innovazione-farmaci-deve-essere-valutata-dallema/ 2016-05-13T11:02:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/baxter-crescita-del-4-entro-il-2020/ 2016-05-13T12:52:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ministero-salute-nessuno-sconto-per-farmaci-on-line/ 2016-05-13T11:51:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-da-nice-raccomandazione-per-benlysta/ 2020-11-10T08:27:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-top-ten-dei-blockbuster-2016/ 2016-05-13T16:16:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/investitori-a-pharma-difendete-il-valore-dei-farmaci/ 2016-05-13T17:26:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/come-trovare-il-momento-giusto-per-parlare-con-i-medici/ 2016-05-16T08:09:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-caso-glybera-puo-insegnare-qualcosa/ 2016-05-16T19:50:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/baxter1-mld-di-dollari-per-gland-pharma/ 2016-05-16T11:21:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/smart-trasparente-e-donna-e-la-sanita-dei-millenials/ 2016-05-16T12:41:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-life-sciences-cresce-del-65/ 2016-05-16T17:39:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-la-nuova-frontiera-e-il-ddr/ 2020-11-10T08:44:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-partnership-da-8-mln-di-dollari-per-studiare-il-microbioma/ 2016-05-16T16:43:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dermatologia-arriva-mylan-con-un-1-mld-di-dollari/ 2016-05-17T16:18:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-autoimmuni-i-20-farmaci-top-selling-del-2015/ 2016-05-17T17:19:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-acquista-anacor-e-si-lancia-nella-cura-delleczema/ 2020-11-10T08:44:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-farmaci-usa-valeant-pronta-a-sconto-del-40/ 2016-05-17T16:14:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sostituzione-terapeutica-un-percorso-difficile/ 2016-05-17T17:23:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-si-fa-in-due-e-cambiano-le-poltrone/ 2016-05-18T18:16:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/innovativo-dinamico-e-anticiclico-e-il-biotech-italiano/ 2016-05-18T18:16:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/meningococco-b-il-vaccino-gsk-torna-nelle-cliniche-uk/ 2016-05-18T15:01:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-le-dismissioni-antitrust-valgono-2-mld-di-dollari/ 2020-11-10T08:44:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-cambiare-decision-making-sui-trial-clinici-in-italia/ 2016-05-18T16:39:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immunoterapie-via-libera-da-fda-per-tecentriq-roche/ 2016-05-19T13:14:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/deutsche-bank-nel-2016-prezzi-dei-farmaci-in-discesa/ 2016-05-19T13:31:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/opdivo-e-keytruda-le-nuove-certezze-dellimmunoncologia/ 2016-05-21T11:20:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/humira-ufficio-brevetti-usa-dice-si-a-coherus-biosciences-per-farne-copia/ 2016-05-19T17:04:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-regole-certe-per-il-settore-farmaceutico/ 2016-05-19T15:58:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/conferenza-regioni-risorse-certe-per-universalita-ssn/ 2016-05-19T15:23:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-italia-cresce-il-fatturato-nel-2019-nuova-linea-produttiva/ 2016-05-19T15:38:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-hiv-viiv-healthcare-sostiene-il-progetto-epiical/ 2016-05-19T16:43:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nuovo-round-di-studi-clinici-su-entresto/ 2020-11-10T08:44:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/utifar-farmacista-player-del-ssn/ 2016-05-20T13:04:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/almirall-q1-positivo-trainato-dalla-dermatologia/ 2016-05-20T13:11:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mckinsey-lanciare-un-nuovo-farmaco-va-bene-una-volta-su-tre/ 2020-11-10T08:44:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-stop-a-due-produttori-indiani/ 2020-11-10T08:44:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ssn-da-roche-payback-per-51-mln-di-euro-da-terapie-innovative/ 2016-05-20T17:32:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-nuovi-antibiotici-uk-le-aziende-accettino-il-pay-or-play/ 2016-05-20T16:57:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-per-monsanto-offerti-42-miliardi-di-euro/ 2016-05-20T17:25:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gli-informatori-sono-ancora-un-mezzo-valido-per-arrivare-al-medico-due-nuovi-studi/ 2016-05-23T17:28:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/2016-fuga-verso-il-biotech-di-dirigenti/ 2016-05-23T17:28:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-dubbi-su-approvazione-xultophy-novo-nordisk/ 2020-11-10T08:44:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viiv-healthcare-campagna-passaparola-per-terapia-art-precoce/ 2016-05-23T14:15:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-una-campagna-dinformazione-sui-rischi-dei-farmaci-online/ 2016-05-23T14:25:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-via-il-black-triangle-da-champix-pfizer/ 2020-11-10T08:44:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-si-espande-in-italia-acquistato-lo-stabilimento-lodichem/ 2020-11-10T08:44:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-infettive-ecco-le-25-aziende-top-spender-in-pubblicita-sui-giornali/ 2016-05-23T17:34:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fimmg-milillo-ipertensivi-e-antidepressivi-a-rischio-rimborso/ 2016-05-24T17:41:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lombardia-progetto-di-legge-bipartisan-per-obbligo-vaccini-asilo-nido/ 2016-05-24T10:38:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-tripla-a-da-standard-poors/ 2016-05-24T15:50:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-lesodo-del-top-management-cinque-abbandoni-in-sette-mesi/ 2016-05-24T14:44:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/classe-1-per-entresto-novartis-le-linee-guida-lo-promuovono-a-pieni-voti/ 2020-11-10T08:43:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/parkinson-xadago-zambon-arriva-anche-in-gran-bretagna/ 2020-11-10T08:43:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scaccabarozzi-farmindustria-cominciamo-a-parlare-di-efficienza/ 2016-05-25T10:05:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/racca-federfarma-5-proposte-per-la-farmacia-del-futuro/ 2016-05-25T10:20:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bpco-uno-studio-rilancia-breo-gsk/ 2020-11-10T08:43:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-strategia-cocktail-per-il-settore-delloncologia/ 2016-05-25T16:54:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/glucometri-partnership-medtronic-qualcomm-per-dispositivi-wireless/ 2016-05-30T17:10:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/seqirus-csl-a-ottobre-il-primo-vaccino-quadrivalente-da-coltura-cellulare/ 2020-11-10T08:43:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-da-panel-fda-raccomandazione-per-xultophy-novo-nordisk/ 2020-11-10T08:43:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/esclusiva-sanofi-sceglie-il-nuovo-board-di-medivation-ecco-i-nomi/ 2016-05-25T16:06:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/melazzini-aifa-garantire-accessibilita-a-farmaci-innovativi-su-tutto-il-territorio/ 2016-05-26T10:23:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/piano-vaccini-per-antitrust-e-allarme-sostenibilita-le-reazioni-di-aifa-e-farmindustria/ 2016-05-26T17:48:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ecdc-europei-social-media-strumenti-di-buona-sanita/ 2016-05-26T13:06:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nejm-riabilitiamo-i-farmaci-mee-too/ 2016-05-26T18:39:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tecnologia-per-la-salute-verso-il-paziente-3-0/ 2016-05-26T15:23:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-persa-negli-usa-la-causa-per-faramco-contro-la-gotta/ 2020-11-10T08:43:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-approvazione-iglarlixi-di-sanofi-raccomandata-da-panel-fda/ 2020-11-10T08:43:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cartoons-e-industria-farmaceutica-la-top-ten-degli-ultimi-decenni/ 2016-05-31T13:47:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-garavaglia-e-venturi-entrano-nel-cda/ 2016-05-26T17:02:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-pronti-alla-cessione-delle-quote-roche/ 2016-05-26T18:38:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/piano-vaccini-botta-e-risposta-aifa-farmindustria/ 2016-05-26T18:37:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ssn-81-milioni-di-risparmio-minimo-con-la-ricontrattazione-dei-farmaci/ 2016-05-30T17:07:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-apple-si-prepara-a-conquistare-il-mercato/ 2016-05-27T11:22:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-e-sanofi-sfida-per-un-mercato-da-6-mld-di-dollari/ 2016-05-27T11:37:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/virus-zika-le-big-pharma-rallentano-sul-vaccino/ 2020-11-10T08:43:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/device-fda-approva-primo-impianto-per-trattare-dipendenza-da-oppiacei/ 2016-05-30T17:08:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/intervista-a-mazzotta-sanofi-piu-otc-in-farmacia-fanno-bene-anche-al-ssn-con-lo-switch-dalletico-al-farmaco-da-banco-migliorano-salute-e-risparmio/ 2016-05-30T17:12:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-da-fda-ok-per-avonex-biogen-e-zinbryta-abbvie/ 2020-11-10T08:43:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epatite-c-chmp-favorevole-a-trattamento-combinato-di-gilead-guerra-di-brevetto-con-merck/ 2020-11-10T08:43:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sondaggio-big-pharma-bayer-in-testa-per-reputazione-abbvie-novo-nordisk-e-merck-le-piu-affidabilik/ 2016-05-30T17:03:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-rare-ue-approva-prima-terapia-genica-firmata-gsk/ 2020-11-10T08:43:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/g7-proposta-uk-15-mld-di-dollari-per-ogni-nuovo-antibiotico-messo-a-punto/ 2016-05-30T17:04:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mieloma-multiplo-recidivante-takeda-chiede-a-chmp-revisione-per-ninlaro/ 2020-11-10T08:43:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-samsung-bioepis-produrra-infliximab-a-biogen-la-distribuzione-europea/ 2020-11-10T08:43:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pani-aifa-37-nuovi-antibiotici-in-fase-di-sviluppo/ 2016-05-31T12:34:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobiotec-italia-spende-4-mld-di-euro-per-farmaci-biotecnologici/ 2016-05-31T15:46:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-derby-roche-novartis-sul-piatto-14-mld-di-dollari/ 2016-06-01T10:19:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-e-riviste-un-business-ancora-vivo-parola-di-bmj/ 2016-05-31T14:57:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epatite-c-oms-farmaci-ancora-troppo-cari/ 2016-06-01T12:52:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattia-di-fabry-da-ue-via-libera-a-migalasat-amicus-therapeutics/ 2016-06-01T12:50:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/corea-di-huntington-fda-nuovi-test-clinici-per-farmaco-teva/ 2020-11-10T08:43:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-per-luglio-nuove-linee-guida-sperimentazione-dei-farmaci/ 2016-06-01T11:38:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ministero-salute-circa-2000-segnalazioni-di-scambi-di-farmaci-in-cinque-anni/ 2016-06-01T12:00:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-tipo-2-ok-chmp-per-combinazione-farmaci-astrazeneca/ 2016-06-01T12:50:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-nuovo-studio-evidenzia-rischi-per-zynbryta-biogen/ 2020-11-10T08:43:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-al-congresso-asco-roche-presente-con-19-farmaci/ 2016-06-01T14:37:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nestle-debutta-nellhealth-100-mln-di-euro-per-un-test-allergologico/ 2016-06-01T15:46:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medici-di-famiglia-9-su-10-preferiscono-ricevere-gli-informatori-farmaceutici-bocciati-telefono-e-social/ 2016-06-03T11:07:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rapporto-ims-la-spesa-globale-per-i-farmaci-contro-il-cancro-superera-i-150-miliardi-di-dollari-entro-il-2020/ 2016-06-03T11:24:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-a-grunenthal-i-diritti-europei-di-zurampic/ 2016-06-06T10:29:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aiom-70-pazienti-supera-la-malattia-per-cancro-in-italia-sfida-sostenibilita/ 2016-06-06T10:56:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-micro-merge-per-creare-valore-agli-azionisti/ 2016-06-06T13:13:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-usa-4-su-5-in-commercio-con-pochi-studi-a-sostegno/ 2016-06-06T13:12:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-rare-da-shire-baxalta-nasce-colosso-da-20-miliardi/ 2016-06-06T14:06:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-alleanza-novartis-eisai-per-afinitor-e-lenvima/ 2016-06-06T14:30:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-fda-avvia-processo-di-revisione-per-patch-contro-emicrania/ 2016-06-06T14:30:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/caso-sovaldi-giudice-ribalta-sentenza-gilead-non-dovra-risarcire-merck/ 2016-06-07T11:02:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/asco-farmaci-oncologici-piu-accessibili-in-australia-in-india-i-prezzi-piu-bassi/ 2016-06-07T12:37:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/governo-usa-biden-con-moonshot-70-mld-di-dollari-per-il-futuro-delloncologia/ 2016-06-07T14:49:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-al-polmone-novartis-chiede-a-fda-estensione-per-tafinlar-e-mekinist/ 2016-06-08T07:52:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/asco-deludenti-i-risultati-per-rova-t-di-abbvie-azioni-giu-del-5/ 2016-06-07T17:18:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-entro-il-2019-pronto-il-competitor-del-robot-da-vinci/ 2016-06-07T17:17:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-stop-a-tronxyca-er-oppiaceo-di-pfizer/ 2016-06-07T15:47:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-da-fda-via-libera-a-byvalson-ipertensione/ 2016-06-07T15:54:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-con-bexsero-gsk-insidia-la-leadership-di-sanofi/ 2016-06-08T10:14:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-oppioidi-fda-non-convinta-su-vantrela-er-teva/ 2020-11-10T08:43:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/infezioni-nosocomiali-farmaco-merck-sotto-lente-ingrandimento-fda/ 2016-06-09T14:45:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-maximulta-a-genentech-per-dati-su-tarceva/ 2020-11-10T08:43:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/melazzini-aifa-registri-di-monitoraggio-utili-per-allocare-risorse/ 2016-06-08T17:13:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/disabilita-sanofi-genzyme-lancia-il-contest-maketocare/ 2016-06-08T17:35:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-gioca-le-sue-carte-per-acquisire-medivation-gliead-e-astrazeneca-entrano-nella-partita/ 2016-06-10T06:57:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/miastenia-non-convincono-i-dati-di-soliris/ 2020-11-10T08:43:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ixekizumab-di-eli-lilly-efficace-nella-psoriasi-a-placche/ 2020-11-10T08:43:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dopo-lo-stop-fda-parere-positivo-di-esperti-usa-su-oppioide-di-pfizer/ 2020-11-10T08:43:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ddl-concorrenza-verso-tetto-regionale-del-20-a-catene-farmacie/ 2016-06-09T16:34:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-farmaci-per-efpia-vanno-calcolati-sullefficacia-non-sui-volumi-di-vendita/ 2020-11-10T08:43:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-rare-accordo-takeda-ultragenyx-da-65-mln-di-dollari/ 2016-06-10T10:54:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumori-nuova-strategia-genetica-per-il-vaccino-linteresse-del-biotech/ 2016-06-10T12:18:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-kit-diagnostico-universita-di-cambridge-vince-leuropean-inventor-award/ 2016-06-10T14:05:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/millenials-doctors-e-pharma-un-rapporto-tutto-da-costruire/ 2016-06-10T15:00:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-per-barrons-e-la-piu-stimata-dagli-investitori/ 2016-06-10T15:29:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-merck-acquista-afferent-pharmaceuticals/ 2016-06-13T17:44:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-fda-approva-paxvax-primo-anticolera-a-singola-dose/ 2016-06-13T11:24:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-farmaci-negli-usa-pfizer-aumenta-di-circa-il-9/ 2016-06-13T12:06:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-sempre-piu-a-misura-di-donna-nei-consumi-e-nella-leadership/ 2016-06-13T13:27:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-samsung-bioepis-spinge-sullacceleratore-con-dati-long-term/ 2020-11-10T08:43:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/infezioni-nosocomiali-marcia-indietro-di-fda-su-zinplava-merck-sharpdome/ 2016-06-13T15:35:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-tipo-2-lixilan-sanofi-raggiunge-gli-obiettivi-clinici-ora-la-parola-allfda/ 2016-06-13T16:02:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valeant-dismissioni-in-vista/ 2016-06-13T16:18:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tecnologie-microsoft-rileva-linkedin-per-262-mld-di-dollari/ 2016-06-13T16:26:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/reuters-ecco-i-100-atenei-piu-innovativi-deuropa-in-italia-spicca-il-politecnico-di-milano/ 2016-06-14T17:24:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-congresso-ada-toujeo-sanofi-efficace-nella-pratica-clinica/ 2016-06-14T13:37:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-il-biosimilare-mk-1293-msd-raggiunge-tutti-gli-obiettivi-clinici/ 2020-11-10T08:43:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/congresso-ada-le-big-pharma-si-sfidano-a-tutto-campo/ 2016-06-14T18:18:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibd-shire-interessata-a-farmaco-sperimentale-pfizer/ 2016-06-14T15:54:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-troppe-aziende-focalizzate-sullo-stesso-approccio-in-oncologia/ 2016-06-14T16:40:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-rare-amicus-therapeutics-apre-sede-a-milano/ 2016-06-15T12:29:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epilessia-e-farmaci-tra-off-label-generici-e-piani-terapeutici/ 2016-06-15T16:27:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otc-italia-impennata-dei-farmaci-contro-acidita-di-stomaco/ 2016-06-15T16:07:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/superbatteri-in-usa-7-nuovi-antibiotici-in-fase-3/ 2016-06-15T17:02:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-chi-vendera-di-piu-nel-2016/ 2016-06-16T07:19:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epatite-c-melazzini-in-italia-farmaco-con-il-prezzo-piu-basso/ 2016-06-15T17:14:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-generazione-y-like-johnson-johnson/ 2016-06-16T14:38:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/actuallyshecan-allergan-dalla-parte-delle-donne/ 2016-06-16T14:38:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-generici-senato-usa-presenta-disegno-di-legge-antitrust/ 2016-06-16T16:45:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/advertising-chi-vincera-i-pharma-lions-a-cannes/ 2016-06-16T14:53:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-fda-pubblica-guida-rischibenefici/ 2016-06-16T15:11:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antibiotici-via-libera-da-fda-cinese-a-taigexyn-taigen-biotech/ 2020-11-10T08:43:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pari-opportunita-a-eli-lilly-italia-il-premio-azienda-women-friendly/ 2016-06-16T16:56:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/disclusure-code-la-trasparenza-come-regola-eticama-attenzione-al-cronista-curioso/ 2016-06-17T16:23:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-finanzia-primo-bando-per-percorsi-innovativi-in-medicina-di-precisione/ 2016-06-16T17:04:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-allergan-accordo-entro-la-fine-del-mese/ 2016-06-17T11:43:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-e-se-i-manager-fossero-retribuiti-sui-risultati-clinici-dei-farmaci/ 2016-06-17T13:55:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-accordo-con-start-up-di-los-angeles-per-area-malattie-croniche/ 2016-06-17T15:11:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-disclosure-code-cambiamento-epocale/ 2016-06-17T15:33:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-rivoluzione-al-vertice-dopo-il-ceo-lascia-anche-il-vaccines-chairman/ 2016-06-17T15:47:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-molto-bene-il-trial-di-keytruda-msd-azioni-in-salita/ 2016-06-17T16:15:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-allattacco-di-humira-e-enbrel-cinque-nuovi-biosimilari-entro-il-2020/ 2016-06-20T09:44:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lions-health-i-vincitori-dellindustria-farmaceutica/ 2016-06-20T09:53:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spedizioni-di-farmaci-da-farmacie-online-illegali-fedex-assolta/ 2016-06-20T13:27:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/quando-il-mobile-health-non-funziona-un-esempio-concreto/ 2016-06-20T13:57:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-italia-seconda-ue-per-velocita-autorizzazione/ 2016-06-20T14:40:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/equivalenti-dalla-sifac-le-linee-guida-per-un-impiego-razionale-e-consapevole/ 2016-06-20T14:55:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-anti-vegf-non-ce-costo-efficacia-nelledema-maculare-diabetico/ 2020-11-10T08:43:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-eli-lilly-punta-sui-prodotti-maturi-e-su-jardiance/ 2016-06-21T18:11:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dal-consiglio-dei-ministri-via-libera-a-misure-su-payback-farmaci/ 2016-06-21T13:23:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-il-punto-di-vista-dei-5-stelle/ 2016-06-21T18:00:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-per-gli-analisti-e-pronta-ad-affrontare-la-battaglia-dei-generici/ 2016-06-21T15:50:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-anche-i-farmacisti-contro-le-campagne-dtc/ 2016-06-21T16:02:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-bene-la-triplice-terapia-per-patologie-croniche-polmonari/ 2016-06-21T16:33:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/google-indossa-il-camice-nasce-un-nuovo-servizio-dedicato-alla-medicina/ 2016-06-22T07:46:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jama-piu-visite-degli-informatori-maggiori-prescrizioni-di-branded/ 2016-06-22T15:59:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/informatori-scientifici-nel-pharma-guadagnano-di-meno-soprattutto-le-donne/ 2016-06-22T08:50:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/generici-teva-accelera-le-dismissioni-si-avvicina-laccordo-con-allergan/ 2016-06-22T11:22:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-shopping-in-usa-acquisito-lasset-cardio-di-the-medicines-company/ 2016-06-22T15:01:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/advertising-farmaceutico-cosa-insegnano-i-lions-health/ 2016-06-22T16:40:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-scaccabarozzi-presidente-fino-a-giugno-2018/ 2016-06-23T12:19:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assogenerici-non-serve-rincorrere-le-emergenze-nella-spesa-farmaceutica/ 2016-06-23T16:51:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nice-green-light-a-farmaci-di-novartis-abbvie-sanofi-e-amgen/ 2016-06-23T17:37:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brevetti-farmaci-la-corte-suprema-usa-non-riforma-la-revisione-inter-pares/ 2016-06-23T15:48:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-settore-in-salute-litalia-puo-diventare-hub-europeo/ 2016-06-23T17:39:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lorenzin-aifa-sempre-piu-come-fda/ 2016-06-23T16:38:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/governance-de-vincenti-obiettivo-riforma-entro-il-31-dicembre/ 2016-06-23T16:34:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-melazzini-aifa-collante-tra-tutti-gli-stakeholder/ 2016-06-23T16:41:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/payback-sconto-del-10-alle-industrie-per-il-ripiano-20132014/ 2016-06-24T09:55:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexitlorenzin-ripercussioni-sullassistenza-e-la-ricerca-scaccabarozzi-portiamo-la-sede-dellema-in-italia/ 2016-06-24T17:29:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/innovazione-farmaceutica-a-msd-italia-il-premio-internazionale-le-fonti/ 2016-06-24T14:04:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/superbrands-awards-sandoz-premiata-anche-per-il-2016/ 2016-06-24T14:14:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valeant-delude-xifaxan-ma-si-prepara-la-riscossa/ 2016-06-24T17:30:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fibrosi-cistica-nice-orkambi-vertex-efficace-ma-costa-troppo/ 2016-06-24T15:00:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-il-giorno-dopo-quale-futuro-per-le-big-pharma-uk/ 2016-06-24T17:29:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-farmaceutica-big-pharma-preferisce-il-semilavorato/ 2020-11-10T08:43:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-al-biotech-il-conto-piu-salato/ 2016-06-27T13:17:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-ema-e-presto-per-valutare-conseguenze/ 2016-06-27T13:59:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cdc-flumist-astrazeneca-inefficace-nella-protezione-antinfluenzale/ 2020-11-10T08:43:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-pronta-una-nuova-strategia-per-arrivare-a-medivation/ 2016-06-27T15:22:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-boeringher-ingelheim-scambio-di-asset-strategici/ 2016-06-27T15:13:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-in-italia-anche-lorenzin-dice-si/ 2016-06-27T15:29:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-italia-presentata-strimvelis-prima-terapia-genica-con-cellule-staminali/ 2016-06-27T18:09:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genoma-la-francia-stanzia-745-milioni-di-dollari-per-il-sequenziamento/ 2016-06-28T10:16:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/st-jude-medical-marchio-ce-a-nuovo-software-per-pace-maker-real-time/ 2016-06-28T15:59:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-dallitalia-130-mln-al-global-fund-lapprezzamento-di-bill-gates/ 2016-06-28T11:49:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-takeda-si-riorganizza-e-punta-sulle-terapie-first-in-class/ 2020-11-10T08:43:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jama-negli-usa-aumentano-i-costi-ospedalieri-out-of-pocket/ 2016-06-28T15:59:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-spesa-farmaceutica-gia-16-mln-oltre-il-tetto-programmato/ 2016-06-28T13:58:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/premio-le-fonti-scaccabarozzi-ceo-2016-per-la-pharmaceutical-innovation/ 2016-06-28T14:13:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-a-immissione-in-commercio-di-ocrelizumab-da-fda-ed-ema/ 2020-11-10T08:43:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rimborsabilita-farmaci-fimmg-preme-per-ritiro-determina/ 2016-06-29T10:30:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sistemi-di-supporto-computerizzati-ma-le-linee-guida-personalizzate-aiutano-medici-a-decidere-due-trial-made-in-italy-cercano-di-scoprirlo/ 2016-07-01T13:40:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/advertising-big-pharma-torna-a-investire-156-nel-2015/ 2016-07-01T15:21:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-tipo-2-primo-ok-da-fda-per-estensione-claim-jardiance/ 2020-11-10T08:42:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shire-obiettivo-raggiunto-per-farmaco-sperimentale-adhd/ 2020-11-10T08:42:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/generici-laustraliana-mayne-pharma-compra-42-prodotti-da-teva-e-allergan/ 2020-11-10T08:42:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/linfoma-fallisce-collaborazione-abbvie-infinity-per-farmaco-biotech/ 2016-07-01T15:21:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fimmg-e-aifa-collaborazione-piu-stretta-anche-sui-farmaci-dei-piani-terapeutici/ 2016-07-01T13:31:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/disclosure-code-il-70-delle-aziende-ha-gia-pubblicato-i-dati/ 2016-07-01T13:53:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rd-allergan-investe-nel-biotech-asiatico/ 2016-07-04T16:57:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/credit-suisse-piccoli-accordi-di-ma-per-il-dopo-medivation/ 2016-07-04T13:35:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/federfarma-allarme-spesa-farmaci-278-in-dieci-anni/ 2016-07-04T15:33:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ematologia-per-imbruvica-abbvie-e-jj-possibili-nuove-indicazioni/ 2020-11-10T08:42:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-medtronic-presenta-domanda-allfda-per-pancreas-artificiale/ 2016-07-04T15:35:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nejm-il-vaccino-anti-malaria-mosquirix-gsk-piu-efficace-con-quattro-dosi/ 2016-07-04T14:53:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/renzi-pronti-a-lavorare-con-sala-per-ema-a-milano/ 2016-07-04T15:49:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/disclosure-code-usa-nel-2015-dalle-aziende-752-mld-di-dollari/ 2016-07-05T10:44:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-accordo-con-biotech-per-nuovo-studio-su-opdivo/ 2016-07-05T12:11:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-ok-a-primo-device-per-la-presbiopia-tra-i-finanziatori-johnson-johnson/ 2016-07-05T12:25:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-almirall-teme-il-caos-per-eventuale-spostamento-ema/ 2016-07-05T14:37:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-gsk-firma-accordo-di-collaborazione-con-universita-di-palermo-per-sviluppo-nuovi-farmaci/ 2016-07-05T16:08:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-roche-ha-rispettato-gli-obblighi-di-vigilianza/ 2016-07-05T16:24:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medivation-financial-times-firmati-accordi-di-riservatezza-con-sanofi-pfizer-e-celgene/ 2016-07-06T09:14:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/asma-teva-scende-in-campo-nella-sfida-ad-advair-gsk/ 2016-07-06T11:16:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-taglia-posti-di-lavoro-in-usa-per-potenziare-rd/ 2016-07-06T17:41:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pma-merck-sostiene-il-grant-for-fertility-innovation-201617/ 2016-07-06T17:39:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-ok-da-commissione-europea-a-daclizumab-biogen-e-abbvie/ 2020-11-10T08:42:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-ok-fda-per-absorb-bvs-lo-stent-che-si-dissolve-dopo-3-anni/ 2016-07-06T17:40:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-spin-off-smith-nephew-va-al-nasdaq-con-ipo-di-150-milioni-di-dollari/ 2016-07-06T14:14:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-genzyme-arruolato-il-primo-paziente-per-lo-studio-ascend-sullolipudase-alfa/ 2020-11-10T08:42:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-la-corte-federale-degli-usa-frena-lingresso-sul-mercato/ 2016-07-07T12:37:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-genentech-sigla-accordo-con-start-up-per-farmaci-chemotype-evolution/ 2020-11-10T08:42:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ssn-per-gli-esperti-migliorano-le-performance-e-diminuisce-il-divario-fra-asl/ 2016-07-07T13:23:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zika-sanofi-partner-dellesercito-americano-per-sviluppo-vaccino/ 2016-07-07T13:36:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-continua-la-crescita-della-bu-estetica/ 2016-07-07T13:47:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/psoriasi-a-placche-ok-a-ixekizumab-da-3-studi-di-fase-iii/ 2020-11-10T08:42:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-alle-ovaie-al-via-studio-per-testare-avelumab-pfizer-e-merck-kgaa/ 2020-11-10T08:42:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/disclosure-code-e-stata-fatta-vera-trasparenza/ 2016-07-07T16:43:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medivation-il-ceo-alza-la-posta/ 2016-07-08T16:10:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-gilead-aumenta-i-prezzi-delle-versioni-old-per-favorire-i-nuovi/ 2016-07-08T16:10:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-task-force-del-governo-britannico-con-gsk-e-astrazeneca/ 2016-07-08T11:08:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/forbes-da-le-pagelle-a-big-pharma-bms-e-jj-su-tutte/ 2016-07-08T15:44:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nomina-coletto-per-melazzini-aifa-valore-aggiunto-per-la-sanita-italiana/ 2016-07-08T11:56:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-via-libera-dai-cdc-a-vaxchora-paxvax-single-dose-contro-il-colera/ 2020-11-10T08:42:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sindrome-di-down-gruppo-menarini-sponsor-dei-trisome-games-a-firenze/ 2016-07-08T12:28:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-presto-nuove-linee-guida-per-test-sequenziamento-geni/ 2016-07-08T15:23:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-quello-di-amgen-e-troppo-simile-a-humira/ 2016-07-11T17:27:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-roche-verso-lacquisto-di-biomarin/ 2020-11-10T08:42:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-sophono-medtronic-studia-impianto-cocleare-a-trasmissione-cutanea/ 2016-07-11T16:58:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-geniche-fda-blocca-studio-juno-therapeutics/ 2016-07-11T16:56:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-zingaretti-scrive-a-raggi-prepariamo-un-dossier-per-roma/ 2016-07-11T15:41:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biopharma-ad-antonio-messina-merck-italia-la-laurea-honoris-causa-in-chimica-e-tecnologie-farmaceutiche/ 2016-07-11T15:49:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/adhd-buone-performance-dal-candidato-di-shire-green-light-per-il-2017/ 2020-11-10T08:42:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epatite-c-da-ce-ok-allimmissione-in-commercio-di-epclusa-gilead/ 2016-07-11T16:44:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/analisi-digitali-dei-tessuti-cresce-il-mercato-in-vetta-3scan-e-philips/ 2016-07-12T14:10:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oftalmologia-shire-ottiene-lok-da-fda-per-xiidra-per-gli-analisti-sara-un-blockbuster/ 2020-11-10T08:42:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-globaldata-il-candidato-gsk-per-il-meningococco-rivoluzionera-il-mercato/ 2020-11-10T08:42:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-fino-al-2025-le-vendite-cresceranno-a-due-cifre/ 2016-07-12T18:15:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-10-mld-di-dollari-per-medivation/ 2016-07-12T18:04:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/artrite-reumatoide-positivo-trial-clinico-per-neuromodulatore-di-setpoint-medical-gsk/ 2016-07-12T16:21:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-ipo-a-euronext-per-inventiva-partner-di-boeringher-inghelheim-e-abbvie/ 2016-07-12T16:51:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-accordo-bayer-x-chem-per-scoprire-nuovi-farmaci/ 2016-07-13T17:29:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-farmacisti-comunitari-del-nhs-quale-futuro/ 2016-07-13T12:25:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-parere-favorevole-unanime-a-biosimilare-di-amgen/ 2016-07-13T12:46:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otorinolaringoiatria-fda-amplia-indicazioni-per-nuvent-medtronic/ 2016-07-13T17:28:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/leucemia-per-ema-zydelig-gilead-puo-restare-in-commercio/ 2016-07-13T14:24:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/colesterolemia-fda-approva-device-per-somministrazione-once-monthly-di-repatha-amgen/ 2016-07-13T17:29:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-corte-distrettuale-california-assolve-gilead-da-concorrenza-sleale/ 2016-07-13T17:27:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-pace-tra-astrazeneca-e-sandoz-per-brevetto-faslodex/ 2016-07-14T10:47:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/parkinson-buoni-risultati-per-tasigna-oncologico-di-novartis/ 2020-11-10T08:42:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-al-seno-al-via-studio-clinico-per-combo-lilly-boeringher-inghelheim/ 2020-11-10T08:42:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-fda-approva-estensione-di-prevnar-13-pfizer/ 2016-07-14T13:55:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-ce-approva-adcetris-come-terapia-di-consolidamento-post-trapianto-nel-linfoma-di-hodgkin/ 2020-11-10T08:42:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-diasorin-lancia-test-molecolare-rapido-per-lma/ 2016-07-14T17:13:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/acquisizioni-teva-allergan-alla-stretta-finale/ 2016-07-18T17:17:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-ema-esamina-il-candidato-di-samsung-bioepis-per-humira/ 2016-07-18T17:17:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-ema-accetta-domanda-merck-per-cladribina/ 2016-07-18T16:57:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-ce-estende-revlimid-a-pazienti-con-linfoma-mantellare/ 2020-11-10T08:42:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-stricker-presenta-sonicanchor-primo-dispositivo-ortopedico-con-viti-bioriassorbili/ 2016-07-18T17:16:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-maroni-firmato-documento-che-candida-milano-a-ospitare-lema/ 2016-07-18T16:26:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-azienda-londinese-studiera-il-patrimonio-genetico-di-13-mila-sardi/ 2016-07-18T16:54:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/animal-health-nella-top-ten-delle-aziende-5-big-pharma/ 2016-07-19T10:55:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/emostasi-bayer-stringe-partnership-con-biotech-americana-per-farmaci-e-biomarker/ 2020-11-10T08:42:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-accordo-amgen-daiichi-sankyo-per-conquistare-il-mercato-giapponese/ 2020-11-10T08:42:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hpv-gsk-ottiene-lok-da-fda-cinese-per-cervarix-e-punta-a-vasto-programma-vaccinale/ 2016-07-19T12:23:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-in-india-guerra-giudiziaria-tra-roche-biocon-e-mylan-per-versione-herceptin/ 2016-07-19T12:40:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/marketing-takeda-e-marvel-lanciano-samarium-primo-supereroe-con-ibd/ 2016-07-19T16:58:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sla-risultati-positivi-per-nurown-terapia-cellulare-di-biotech-statunitense/ 2016-07-19T14:30:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-q2-con-segno-positivo-nonostante-entresto/ 2016-07-20T17:21:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zimmer-acquisisce-medtech-e-debutta-nella-chirurgia-robotica/ 2016-07-20T17:21:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-si-scinde-bernstein-dice-no-gli-investitori-si/ 2016-07-20T12:43:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immunoncologia-accordo-triennale-celgene-jounce-therapeutics-per-25-mld-di-dollari/ 2016-07-20T13:41:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-fda-boccia-riproduzione-neulasta-amgen-proposta-da-sandoz/ 2016-07-20T13:58:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-bene-il-q2-e-azioni-record/ 2016-07-20T15:06:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-ok-da-panel-a-brodalumab-valeant-ma-lazienda-dovra-monitorare-il-rischio-suicidio/ 2016-07-20T17:21:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-a-johnson-johnson-il-primo-round-su-remicade/ 2016-07-21T16:19:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-da-eib-25-milioni-di-euro-a-biotech-francese-per-malattia-di-lyme-e-zika/ 2016-07-21T16:18:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-qtern-astrazeneca-first-to-market-in-europa/ 2016-07-21T17:20:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immunoncologia-round-di-57-mln-di-dollari-a-start-up-americana-per-lavorare-sui-tumori-cerebrali/ 2020-11-10T08:42:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-per-prevnar-13-pfizer-nuova-formulazione-approvata-dalloms/ 2020-11-10T08:42:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/elezioni-usa-per-jimenez-ceo-novartis-cambiera-politica-prezzi-dei-farmaci/ 2016-07-21T17:48:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-rialzo-del-4-sullutile-netto-nel-q2/ 2016-07-21T17:13:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pancreas-artificiale-una-start-up-usa-sfida-medtronic/ 2016-07-25T13:08:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aids-via-libera-chmp-a-truvada-gilead-per-prep-in-europa/ 2016-07-26T09:54:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-al-rene-ema-raccomanda-cabometyx-ipsen-e-kisplyx-eisai/ 2016-07-26T10:13:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gileadq2-soffre-il-mercato-hcv-bene-le-terapie-per-laids/ 2016-07-26T11:21:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-q2-volumi-farmaceutica-in-crescita-del-10-guadagni-a-9/ 2016-07-27T10:45:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-allergan-e-fatta-lantitrust-usa-dice-si/ 2016-07-28T09:45:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-sfida-la-brexit-e-investe-in-uk-per-275-mln-di-sterline/ 2016-07-28T11:46:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epatite-c-da-commissione-europea-ok-a-zapatier-msd/ 2016-07-29T15:18:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/da-gsk-e-verily-life-sciences-nasce-galvani-bioelectronics-produrra-farmaci-bio-elettronici-in-uk/ 2016-08-01T11:21:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/artrite-reumatoide-ema-valuta-ok-per-sarilumab-sanofi-e-regeneron/ 2016-08-01T14:15:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-fusione-con-novartis-allorizzonte/ 2016-09-02T13:45:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-humira-super-trascina-il-q2/ 2016-08-04T11:36:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-da-commissione-europea-ok-a-keytruda-per-carcinoma-polmonare-nsclc/ 2016-08-03T12:27:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-antinfluenzale-universale-al-via-trial-di-redeeflu-flugen/ 2020-11-10T08:42:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ddl-concorrenza-assogenerici-il-patent-linkage-lascia-indietro-litalia/ 2016-08-03T14:46:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-un-mese-dopo-gsk-sorride-anche-grazie-alla-sterlina-debole/ 2016-08-04T11:36:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-al-seno-per-fda-trattamento-novartis-e-breakthrough-therapy/ 2016-08-04T11:35:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-33-miliardi-di-dollari-di-liquidita-quali-le-prossime-mosse/ 2016-09-02T14:05:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-siponimod-novartis-raggiunge-endpoint-primario-in-studio-fase-iii/ 2016-08-26T12:20:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shopping-pfizer-acquista-medivation-e-antibiotici-astrazeneca/ 2016-09-02T13:40:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/st-jude-medical-il-46-dei-device-e-a-rischio-attacco-informatico/ 2016-08-29T14:37:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/effetto-clinton-per-mylan-che-lancia-versione-generica-di-epipen/ 2016-09-05T17:52:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-cessione-quote-roche-alle-porte-in-germania-dicono-si/ 2016-09-02T13:59:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/da-fda-via-libera-a-erelzi-sandoz-terzo-biosimilare-in-commercio-negli-usa/ 2016-09-05T17:49:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-solo-1-europeo-su-3-li-conosce-e-non-li-teme/ 2016-09-05T17:51:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ecco-i-finalisti-del-premio-letterario-leggi-in-salute-angelo-zanibelli-premiazione-il-4-ottobre/ 2016-09-02T13:55:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-novartis-legge-e-contenzioso-potrebbero-bloccare-il-lancio-di-erelzi/ 2016-09-05T17:50:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-quando-il-merger-e-un-affare-per-il-ceo/ 2016-09-02T13:35:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-fda-approva-primo-dispositivo-bluetooth-per-mercato-americano/ 2016-09-05T17:18:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-al-via-studio-con-5000-pazienti-su-mieloma-multiplo/ 2016-09-05T17:50:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-efficace-terapia-combinata-per-bpco-lo-studio-su-nejm/ 2016-09-05T12:24:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-orfani-ecco-la-top-ten-dei-leader-di-mercato/ 2016-09-06T08:13:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-medici-nestle-acquisisce-phagenyx-per-il-controllo-neurologico-della-deglutizione/ 2016-09-05T15:40:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/efpia-il-dg-richard-bergstrm-lascia-dopo-5-anni/ 2016-09-05T16:50:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-congresso-usa-chiede-indagine-su-prezzo-epipen/ 2016-09-05T16:57:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/google-accordo-con-nhs-per-testare-intelligenza-artificiale-nei-tumori-di-testa-e-collo/ 2016-09-06T12:52:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alzheimer-da-fda-fast-truck-designation-per-aducanumab-biogen/ 2020-11-10T08:42:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-dopo-16-anni-lascia-il-ceo-lars-sorenen-rebien/ 2016-09-06T13:34:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/asma-benralizumab-astrazeneca-battera-la-concorrenza/ 2020-11-10T08:42:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/digital-health-philips-e-qualcomm-al-lavoro-per-connessione-dispositivi-medici/ 2016-09-06T14:17:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medivation-perche-alla-fine-lha-spuntata-pfizer/ 2016-09-06T14:42:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-amplia-la-sede-di-berlino-e-investe-in-italia/ 2016-09-06T17:00:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sla-fda-esamina-edaravone-mitsubishi-primo-farmaco-dopo-20-anni/ 2020-11-10T08:42:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/st-jude-medical-parte-nuova-sperimentazione-del-device-per-la-fibrillazione-atriale/ 2016-09-07T11:15:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brent-saunders-ceo-allergan-contenere-prezzi-farmaci-per-mantenere-venture-capital-nel-settore/ 2016-09-07T17:39:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/olimpiadi-sul-podio-delladvertising-anche-big-pharma/ 2016-09-07T17:31:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-anche-takeda-in-corsa-per-quello-anti-zika/ 2016-09-07T17:30:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-gsk-punta-sulla-combo-di-due-farmaci-per-battere-gilead/ 2020-11-10T08:42:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-paghera-552-mln-di-dollari-per-caso-di-corruzione-allestero/ 2016-09-07T17:03:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/europa-sanita-digitale-e-uniformita-percorsi-regolatori-i-temi-al-centro-del-meeting-hma/ 2016-09-08T16:48:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-ministro-esteri-giapponese-mantenere-a-londra-la-sede-ema/ 2016-09-08T16:46:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-farmaci-usa-big-pharma-comunica-con-i-dati/ 2016-09-08T14:21:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/leucemia-mieloide-acuta-celgene-scommette-su-partnership-con-agios/ 2020-11-10T08:42:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immunoterapia-accordo-genentech-roche-e-biolinerx-per-testare-combo-di-due-farmaci/ 2020-11-10T08:42:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ictus-fda-approva-la-prima-terapia-combinata-farmaco-device/ 2016-09-08T16:45:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/artrite-reumatoide-commissione-europea-approva-abatacept-bms-in-combinazione-con-metotrexato/ 2020-11-10T08:27:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giuliani-riccardo-zagaria-e-il-nuovo-ad/ 2016-09-09T10:39:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/orphan-drugs-prezzi-stabili-entro-il-2018/ 2016-09-09T12:59:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dengue-al-via-trial-globale-di-tak-003-takeda/ 2020-11-10T08:42:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/read-ceo-pfizer-controllo-prezzi-europeo-non-valido-per-gli-usa/ 2016-09-09T13:45:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fortune-ornella-barra-walgreens-boots-alliance-tra-le-prime-dieci-donne-piu-influenti-del-mondo/ 2016-09-09T15:17:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immunoterapia-dal-giappone-una-rivale-per-amgen/ 2016-09-09T15:16:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-condannati-i-vertici-annunciato-il-ricorso-in-appello/ 2016-09-11T17:04:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-monsanto-val-bene-la-divisione-dermatologia/ 2016-09-12T11:12:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-nel-2018-lancio-del-competitor-di-epipen/ 2016-09-12T12:41:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-milano-e-pronta-pani-una-grande-opportunita-per-il-settore/ 2016-09-12T12:41:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/carenza-farmaci-fronte-comune-tra-aifa-associazioni-di-settore-lazio-e-lombardia/ 2016-09-12T13:02:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pay-for-delay-a-lundbeck-multa-da-93-milioni-di-euro/ 2016-09-12T16:54:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-nei-lea-obiettivo-95-copertura-costa-620-mln-di-euro/ 2016-09-12T17:13:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/keytruda-opdivo-testa-a-testa-che-appassiona-il-mercato/ 2020-11-10T08:42:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antibiotico-resistenza-trial-clinici-uniformi-per-sconfiggerla/ 2016-09-12T17:47:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/leucemia-funziona-combo-lirilumabopdivo-e-yervoy-bms/ 2020-11-10T08:41:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-da-sanofi-e-google-nasce-onduo-un-accordo-da-500-mln-di-dollari/ 2016-09-13T13:03:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-obiettivo-crescita-del-5-ma-copaxone-fa-gola-ai-competitor/ 2020-11-10T08:41:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chirurgia-arriva-telelap-alf-x-sistema-3d-che-segue-la-testa-delloperatore/ 2016-09-13T15:47:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hpv-janssen-achillion-triplice-combo-da-1-mld-di-dollari/ 2020-11-10T08:41:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giornata-mondiale-della-sepsi-assobiomedica-politiche-omogenee-di-prevenzione/ 2016-09-13T17:09:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-infiammatorie-da-novartis-17-mln-di-dollari-su-candidato-start-up-irlandese/ 2016-09-14T11:15:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-forxiga-anche-per-patologie-cardiovascolari-e-renali-al-via-due-studi/ 2020-11-10T08:41:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-con-onduo-un-passo-avanti-verso-la-digital-health/ 2016-09-14T12:43:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giornata-mondiale-linfomi-al-via-contest-fotografico-per-i-centri-ematologici-italiani/ 2016-09-14T13:55:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-monsanto-accordo-fatto-nasce-il-colosso-del-farming-mondiale/ 2016-09-14T17:14:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-troppi-addetti-impegnati-come-polizia-del-botox/ 2016-09-14T14:47:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/influenza-610-mln-a-biotech-americana-per-vaccino-in-caso-di-epidemia/ 2020-11-10T08:41:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/referendum-frattini-medtronic-lambasciatore-phillips-ha-ragione/ 2016-09-14T16:25:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nomine-tascione-nuovo-ceo-di-zambon/ 2016-09-15T17:34:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/csr-baxter-nellindice-mondiale-della-sostenibilita-dow-jones-e-la-17ma-volta/ 2016-09-15T12:25:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-ocrevus-roche-farmaco-golden-bullet/ 2020-11-10T08:41:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/asma-benralizumab-astrazeneca-futuro-best-in-class/ 2016-09-15T13:35:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/paralisi-spinale-efficace-terapia-con-staminali-di-biotech-californiana/ 2016-09-15T14:22:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/polmonite-il-caso-clinton-trascina-la-domanda-dei-vaccini/ 2016-09-15T14:50:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/industria-vaccini-fusioni-e-acquisizioni-allorizzonte/ 2020-11-10T08:41:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-da-novembre-operativo-nuovo-sistema-per-bollini/ 2016-09-16T12:03:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shire-al-via-campagna-mondiale-su-malattia-di-gaucher/ 2016-09-16T12:15:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/device-otsuka-punta-tutto-su-blister-3-0/ 2016-09-16T13:42:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/payback-tar-lazio-sospende-i-provvedimenti-20132015/ 2016-09-16T15:02:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vendite-farmaci-nel-20022-sara-testa-a-testa-roche-novartis/ 2016-09-16T14:40:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmacovigilanza-luca-pani-direttore-del-gruppo-strategico-europeo/ 2016-09-16T14:46:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-easd-bene-sanofi-con-combo-iglarlixi-e-toujeo-insulina-glargine/ 2020-11-10T08:41:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/corea-di-huntington-teva-e-intel-insieme-per-dispositivo-indossabile/ 2016-09-19T15:33:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/emicrania-50-di-episodi-in-meno-con-amg-novartis/ 2020-11-10T08:41:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immunoncologia-pfizer-cambia-strategia-lavorera-con-biotech-americana/ 2020-11-10T08:41:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/animal-health-merck-si-rafforza-con-harrisvaccines/ 2020-11-10T08:41:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-vende-alcon-no-o-forse-si/ 2016-09-19T14:58:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-monsanto-e-stato-davvero-un-grande-affare/ 2016-09-19T14:45:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rifugiati-antibiotici-epidemie-gsk-tre-obiettivi-di-salute-pubblica-da-discutere-allonu/ 2016-09-19T17:34:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cmv-risultati-negativi-per-il-vaccino-astellas/ 2020-11-10T08:41:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-cerca-il-rilancio-di-entresto-con-nuovi-dati/ 2020-11-10T08:41:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-dal-18-gennaio-scatta-lobbligo-di-pubblicare-i-risultati-fallimentari-degli-studi-sui-farmaci/ 2016-09-20T16:39:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-proibisce-la-vendita-in-ue-dei-farmaci-di-pharmaceutics-international/ 2016-09-20T16:44:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-approva-kyleena-il-contraccettivo-ormonale-di-bayer/ 2020-11-10T08:41:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-per-il-dopo-pani-si-proceda-a-bando-pubblico-europeo/ 2016-09-20T16:36:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-emma-walmsley-nuovo-ceo-e-la-prima-donna-a-capo-di-una-big-pharma/ 2016-09-21T17:06:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chikungunya-alleanza-india-giappone-per-vaccino/ 2020-11-10T08:41:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antibiotico-resistenza-big-pharma-fissa-obiettivi-per-il-2020/ 2016-09-21T11:34:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aterosclerosi-bene-repatha-amgen-in-studio-fase-iii/ 2020-11-10T08:41:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-obiettivo-nash-2-mld-di-dollari-per-biotech-americana/ 2020-11-10T08:41:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-in-usa-e-scontro-sanofi-merck/ 2016-09-21T15:59:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/depressione-pfizer-lancia-moodivator-app-per-i-pazienti/ 2016-09-22T10:46:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ue-no-anche-a-cosmetici-con-test-su-animali-fatti-fuori-europa/ 2016-09-22T11:02:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-sifo-promuove-tavolo-di-confronto-sulla-distribuzione/ 2016-09-22T11:53:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/parkinson-abbvie-sceglie-spin-off-karolinska-institute-per-sviluppo-immunoterapia/ 2020-11-10T08:41:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immunoterapia-genentech-roche-punta-su-biotech-tedesca/ 2020-11-10T08:41:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-perrigo-e-sun-pharma-a-chi-lunita-dermatologica-di-bayer/ 2016-09-23T08:00:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-nasce-il-biohub-di-marck-zuckerberg-facebook/ 2016-09-23T16:17:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/contraffazione-sanofi-italia-lancia-a-scuola-di-salute-per-informare-gli-studenti-siciliani/ 2016-09-23T15:13:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-gilead-prossima-mega-fusione/ 2020-11-10T08:41:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-regneneron-co-marketing-per-fasinumab-anti-ngf/ 2020-11-10T08:41:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-antitumorali-nasce-artios-pharma-lavorera-sulle-nuove-classi-di-enzimi/ 2016-09-23T13:57:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-siponimod-novartis-potenziale-blockbuster/ 2020-11-10T08:41:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antibiotico-resistenza-da-governo-usa-incentivi-a-roche-e-medicines-company/ 2016-09-23T14:59:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-in-europa-da-gilead-sciences-uno-sguardo-al-futuro-con-the-long-view/ 2016-09-26T11:11:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-corsa-a-se-per-il-ruolo-di-direttore-geenrale/ 2016-09-26T12:53:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-gsk-lancia-in-italia-click-to-chat-per-rispondere-a-medici-e-cittadini/ 2016-09-26T15:21:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/animal-health-elanco-eli-lilly-punta-sullacquacoltura/ 2020-11-10T08:41:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ssn-ricette-digitali-all80-addio-al-cartaceo-gia-a-dicembre/ 2016-09-26T15:51:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incontinenza-urinaria-appello-societa-scientifiche-per-pac-paziente/ 2016-09-26T17:14:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/comunicazione-premio-janssen-hi-future-per-web-serie-sulla-salute/ 2016-09-27T15:56:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/contraccezione-appello-medici-e-cittadini-per-allineamento-europa/ 2016-09-27T12:03:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobiotech-e-la-settimana-delle-biotecnologie-55-iniziative-in-tutta-italia/ 2016-09-27T12:25:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattia-di-crohn-fda-approva-stelara-johnson-johnson/ 2020-11-10T08:41:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/stimolazione-cerebrale-profonda-ok-fda-per-stealthstation-medtronic/ 2016-09-27T14:44:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dermatite-atopica-per-dupilumab-sanofi-e-regeneron-revisione-prioritaria-di-fda/ 2020-11-10T08:41:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-niente-split-up-generici-branded/ 2016-09-27T16:40:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-zika-usa-finanziano-ricerca-sanofi-con-43-mln-di-dollari/ 2016-09-28T11:11:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-fda-approva-ilaris-canakinumab-per-tre-patologie-rare/ 2020-11-10T08:41:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/digital-health-nasce-in-canada-libm-innovation-space-primo-hub-di-start-up/ 2016-09-28T12:27:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/marketing-bayer-abolira-il-brand-monsanto/ 2016-09-28T14:18:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bisomilari-shire-dismette-biosimilari-di-humira-ed-enbrel/ 2020-11-10T08:41:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-amjevita-amgen-entra-nel-mercato-usa-e-il-biosimilare-di-humira-abbvie/ 2020-11-10T08:41:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-calano-le-vendite-di-prevenar-13-pfizer/ 2020-11-10T08:41:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bpco-ema-valuta-la-tripla-combinazione-di-chiesi-farmaceutici/ 2020-11-10T08:41:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-arriva-negli-usa-il-pancreas-artificiale-di-medtronic/ 2016-09-29T13:19:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mieloma-multiplo-kyprolis-amgen-fallisce-trial-fase-iii/ 2020-11-10T08:41:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jama-malattie-cardiovascolari-top-trend-su-twitter/ 2016-09-29T17:36:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scaccabarozzi-farmindustria-italia-ha-carte-in-regola-per-diventare-hub-di-studi-clinici/ 2016-09-29T16:15:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanita-federfarma-bene-riforma-costituzionale-cittadinanzattiva-un-vantaggio-per-i-lea/ 2016-09-29T17:35:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/apple-nuove-applicazioni-healthkit-per-migliorare-le-diagnosi/ 2016-09-29T16:26:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-brian-mcnamara-nuovo-responsabile-mondiale-consumer-healthcare/ 2016-09-30T13:23:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-celgene-finanzia-start-up-per-primo-farmaco-endocannabinoide/ 2020-11-10T08:40:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/emicrania-amgen-e-novartis-guidano-la-corsa-a-nuova-classe-farmaci/ 2016-09-30T16:36:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/europa-pedicini-m5s-creare-casa-farmaceutica-comunitaria/ 2016-09-30T14:54:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-biotech-sempre-piu-forte-in-italia/ 2016-09-30T15:18:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-in-due-anni-9-di-spesa-farmaceutica/ 2016-09-30T15:46:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lorenzin-la-cultura-scientifica-deve-tornare-nellagenda-politica/ 2016-10-03T09:43:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pediatri-uno-su-3-ricorre-allomeopatia/ 2016-10-03T10:10:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giorgetti-farmindustria-bene-il-lavoro-sulla-medicina-al-femminile/ 2016-10-03T10:17:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-trattamenti-smart-con-app-e-dispositivi-hi-tech/ 2016-10-03T10:26:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-contraffatti-in-italia-bruciati-16-miliardi-di-euro-lanno/ 2016-10-03T10:59:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/degenerazione-maculare-eylea-regeneron-in-combinazione-fallisce-trial-clinico/ 2020-11-10T08:40:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/contraccezione-ormonale-e-depressione-nuovi-dati-dimostrano-collegamento/ 2020-11-10T08:40:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/premio-janssen-hi-future-vince-a-m-i-android-for-medical-innovation-di-andrea-martelli/ 2016-10-03T16:41:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-lancia-spot-my-trial-motore-di-ricerca-per-studi-clinici-destinato-ai-pazienti/ 2016-10-04T15:56:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spesa-farmaceutica-primo-semestre-2016-cala-quella-convenzionata/ 2016-10-04T12:14:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-cinese-falso-l80-dei-test-per-il-mercato-domestico/ 2016-10-04T12:25:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dermatite-atopica-pubblicati-dati-positivi-di-fase-iii-per-dupilumab-sanofi-e-regeneron/ 2020-11-10T08:40:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncoematologia-celgene-acquista-biotech-svizzera-per-600-milioni-di-dollari/ 2020-11-10T08:40:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-big-pharma-vs-big-pharma/ 2020-11-10T08:40:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-no-a-gel-e-tavolette-per-la-dentizione/ 2016-10-04T14:58:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/psoriasi-nella-corsa-al-trattamento-entra-anche-jj-con-guselkumab/ 2020-11-10T08:40:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oftalmologia-continua-la-corsa-di-bayer-acquisita-biotech-finlandese/ 2020-11-10T08:40:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-al-seno-samsung-bioepis-presenta-allema-sb3-biosimilare-di-herceptin/ 2020-11-10T08:40:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ue-stop-a-ema-per-diffusione-documentazione-di-due-farmaci/ 2016-10-05T13:36:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-biotech-usa-lancia-approccio-computer-driven-per-sviluppo/ 2016-10-05T13:55:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-brilinta-astrazeneca-fallisce-due-trial-scommessa-persa/ 2020-11-10T08:40:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-pompa-insulnica-jj-a-rischio-hacking/ 2016-10-05T15:08:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-accordo-amgen-nuevolution-per-sperimentazione-farmaci-su-dna/ 2020-11-10T08:40:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-lancia-crowdsourcing-e-vince-unapp-per-la-depressione/ 2016-10-06T16:14:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-chiude-in-cina-e-apre-in-usa/ 2016-10-06T16:42:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-breakthrough-therapy-per-roactemra-roche-nellarterite-a-cellule-giganti/ 2020-11-10T08:40:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epatite-c-fda-impone-warning-sulle-etichette-dei-farmaci/ 2016-10-06T14:19:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-dengvaxia-sanofi-pasteur-approvato-in-11-paesi/ 2016-10-06T14:38:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-icu-medical-offre-un-mld-di-dollari-a-pfizer-per-ramo-hopsira/ 2016-10-07T11:30:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/parkinson-ok-da-fda-per-infinity-st-jude-nuovo-dispositivo-per-la-dbs/ 2016-10-07T11:18:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-equivalenti-da-teva-italia-200-milioni-di-euro-di-risparmio-per-il-ssn/ 2016-10-07T11:29:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-assobiomedica-registri-dispositivi-obbligatori-per-evitare-sprechi/ 2016-10-07T11:45:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-del-polmone-nice-ok-a-tagrisso-astrazeneca-per-300-pazienti-in-inghilterra-e-galles/ 2020-11-10T08:40:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-sempre-piu-social-ma-deve-fare-di-piu-e-meglio/ 2016-10-07T15:21:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-italia-cambia-la-comunicazione-ecco-la-nuova-struttura/ 2016-10-10T17:01:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-italia-da-certiquality-riconoscimento-gold-per-i-processi-di-gestione/ 2016-10-10T12:20:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-del-polmone-astrazeneca-cede-in-licenza-candidato-per-150-mln-di-dollari/ 2020-11-10T08:40:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/neurologia-biotech-con-base-a-milano-da-il-via-a-due-studi-clinici/ 2020-11-10T08:40:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/effetto-brexit-in-europa-il-25-in-meno-di-fusioni-e-acquisizioni/ 2016-10-10T14:23:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/emirati-arabi-uniti-dove-sanita-fa-rima-con-crescita-economica/ 2016-10-10T14:34:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-al-seno-combo-di-novartis-efficace-nella-progressione-ma-la-leadership-e-di-pfizer/ 2020-11-10T08:39:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-grzegorz-cessak-nuovo-vice-presidente-del-board-via-libera-al-portale-sui-farmaci/ 2016-10-10T15:19:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/animal-health-elanco-eli-lilly-acquista-vaccini-boehringer-ingelheim/ 2020-11-10T08:39:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/caso-epipen-mylan-paga-465-mln-di-dollari-al-governo-usa/ 2016-10-11T12:41:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/saitta-sanita-regioni-patto-nazionale-fra-stakeholder-per-difesa-ssn/ 2016-10-11T12:40:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-e-internet-un-mercato-da-160-mld-di-dollari/ 2016-10-11T13:17:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-del-rene-testa-a-testa-pfizer-exelixis/ 2020-11-10T08:39:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lea-insediata-la-commissione-nazionale-per-laggiornamento/ 2016-10-11T14:06:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biopharma-2016-anno-delle-donne-ecco-la-top-ten-delle-manager/ 2016-10-12T11:29:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-st-jude-richiama-40-mila-defibrillatori-per-difetto-alla-batteria/ 2016-10-12T16:57:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nestle-punta-forte-sulla-dermatologia-preso-executive-di-allergan/ 2016-10-12T12:35:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anticoagulanti-pradaxa-bi-supera-xarelto-jjbayer-in-studio-real-world/ 2020-11-10T08:39:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nice-ok-a-otezla-celgene-per-artrite-psoriasica/ 2020-11-10T08:39:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ict-e-sanita-a-cagliari-il-convegno-annuale-dellaisis/ 2016-10-12T15:50:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/asma-candidato-astrazeneca-fallisce-trial-di-fase-iia/ 2020-11-10T08:39:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-della-prostata-al-via-trial-di-fase-ii-per-combo-prostvacyervoy/ 2020-11-10T08:39:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuovi-antitumorali-accordo-daiichi-sankyo-e-dana-faber-institute-di-boston/ 2020-11-10T08:39:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-riabilita-xarelto-bayerjj-sanguinamenti-minimi/ 2016-10-13T17:08:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-laifa-e-protagonista-in-europa/ 2016-10-13T14:31:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assogenerici-con-equivalenti-risparmi-per-4-mld-ma-in-ospedale-si-preferisce-il-branded/ 2016-10-13T16:38:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-italia-premia-linnovazione-digitale-un-mln-di-euro-per-60-progetti-made-in-italy/ 2016-10-13T16:40:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/donne-nel-pharma-cosa-dicono-quelle-che-ce-lhanno-fatta/ 2016-10-14T17:21:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-al-polmone-zykadia-novartis-piu-efficace-della-chemioterapia-in-studio-fase-iii/ 2020-11-10T08:39:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-teva-irrompe-nel-settore-in-partnership-con-celltrion/ 2020-11-10T08:39:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-cina-e-piu-vicina-tolti-i-dazi-a-30-medical-device/ 2016-10-14T15:29:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-da-chmp-ok-a-venclyxto-venetoclax-per-la-leucemia-linfatica-cronica/ 2020-11-10T08:39:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chmp-nella-sessione-di-ottobre-raccomandati-allema-8-farmaci-di-cui-4-orfani/ 2016-10-14T17:07:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-approvato-il-bando-2016-per-la-ricerca-indipendente/ 2016-10-14T16:30:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/colangite-biliare-primitiva-ema-concede-autorizzazione-condizionata-ad-ocaliva/ 2020-11-10T08:39:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chmp-nuove-indicazioni-per-lucentis/ 2020-11-10T08:39:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/industria-farmaceutica-italiana-lobiettivo-e-il-primo-posto-in-europa/ 2020-11-10T08:39:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scaccabarozzi-la-lombardia-e-modello-di-innovazione/ 2016-10-17T11:05:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-attenzione-ai-farmaci-anti-epatite-c-presi-on-line/ 2020-11-10T08:39:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rivoluzione-farmacie-si-potranno-pagare-bollettini-e-ticket/ 2016-10-17T12:31:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/manovra-da-farmaci-innovativi-a-nuove-assunzioni/ 2016-10-17T12:57:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-efficace-la-combo-lixisenatide-e-insulina-glargine/ 2020-11-10T08:39:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-dal-15-novembre-inflectra-arriva-negli-usa/ 2020-11-10T08:39:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-che-fine-fara-cancer-moonshot/ 2016-10-18T13:09:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-con-ema-a-milano-possibile-sinergia-con-lalimentare-di-parma/ 2016-10-18T16:43:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/manovra-sanita-aiom-sette-nuovi-farmaci-per-migliaia-di-malati/ 2016-10-18T16:44:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/melanoma-aifa-approva-combo-roche-cobimetinib-e-vemurafenib-per-le-forme-avanzate/ 2020-11-10T08:39:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/resposnabilita-sociale-il-progettorete-pediatri-contro-abusi-sui-bimbi-menarini-arriva-a-tirana/ 2016-10-18T15:15:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mario-melazzini-sara-il-nuovo-direttore-generale-dellaifa/ 2016-10-19T18:03:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immunodeficienze-primitive-da-aifa-ok-a-cuvitru-shire/ 2016-10-19T16:47:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antitumorali-bsp-miglior-fornitore-mondiale-per-gli-adc/ 2016-10-19T17:01:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lorenzin-in-manovra-un-miliardo-vincolato-a-farmaci-oncologici-e-fondo-epatite-c/ 2016-10-19T18:15:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/infezioni-ospedaliere-in-europa-i-casi-sono-oltre-due-milioni-e-mezzo/ 2016-10-19T17:18:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/50-mila-italiani-in-dialisi-giro-daffari-per-oltre-25-mld-allanno/ 2016-10-19T17:28:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/produzione-farmaci-italia-leader-nel-mondo-export-all85/ 2016-10-19T17:36:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dolore-lombare-da-fda-stop-a-fasinumab-regeneronteva/ 2020-11-10T08:39:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-st-jude-venduti-a-terumo-il-business-vascolare-e-dellelettrofisiologia/ 2016-10-19T17:44:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ue-illegittimi-i-prezzi-uniformi-dei-medicinali-a-prescrizione-medica/ 2016-10-20T17:49:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/manovra-sanita-da-farmindustria-e-federfarma-plauso-a-lorenzin/ 2016-10-20T08:57:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sindacati-medici-con-manovra-bene-aumento-fondo-ma-priorita-alla-stabilizzazione/ 2016-10-20T09:08:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattia-di-crohn-funziona-device-bio-elettronico-di-gsk/ 2016-10-20T12:34:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-in-usa-strategia-marketing-mix-per-lanciare-biosimilari/ 2016-10-20T12:41:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-via-lbera-da-panel-fda-a-farmaco-sperimentale-contro-la-nicturia/ 2020-11-10T08:39:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-al-polmone-per-tecentriq-roche-ce-lapprovazione-della-fda/ 2016-10-20T13:09:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-premia-gli-uomini-afiancodelcoraggiodelle-donne-col-tumore/ 2016-10-20T18:52:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/stato-regioni-rinviato-parere-su-melazzini-dg-dellaifa/ 2016-10-20T18:10:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/de-filippo-ministero-salute-nel-2017-piano-per-antibiotico-resistenza/ 2016-10-21T09:13:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scaccabarozzi-farmindustria-per-italia-futuro-da-hub-dellinnovazione/ 2016-10-21T09:27:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ssn-arriva-la-spending-review-indolore-risparmi-per-2-miliardi-allanno/ 2016-10-21T09:43:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terremoto-zoetis-finanzia-primo-impianto-coperto-di-addestramento-unita-cinofile/ 2016-10-21T09:54:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-al-polmone-per-oncologi-e-big-pharma-valutazioni-costobeneficio-sbagliate/ 2020-11-10T08:39:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moodys-a-breve-riprenderanno-le-ma-nel-settore-farmaceutico/ 2016-10-21T13:33:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sarcoma-per-latruvo-eli-lilly-arriva-lok-della-fda/ 2020-11-10T08:39:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-inizia-lera-della-trasparenza-libero-accesso-ai-dossier-clinici/ 2016-10-24T10:55:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/presa-la-banda-del-farmaco-avevano-rubato-antitumorali/ 2016-10-24T10:52:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/opdivo-lo-sconto-bms-fa-cambiare-idea-al-nice-ora-e-costo-efficace/ 2020-11-10T08:39:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/keytruda-merck-obiettivo-raggiunto-nel-trial-sul-tumore-alla-prostata/ 2020-11-10T08:39:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/payback-farmaceutica-201315-ecco-i-ripiani-azienda-per-azienda/ 2016-10-24T16:21:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mattarella-stop-ad-affermazioni-sconsiderate-su-vaccini/ 2016-10-24T16:37:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-influenza-al-via-la-campagna-201617-in-futuro-si-fara-in-farmacia/ 2016-10-25T08:46:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/keytruda-merck-ok-dallfda-come-terapia-di-prima-linea-per-il-cancro-al-polmone/ 2020-11-10T08:39:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/emodialisi-baxter-lancia-filtro-per-molecole-grandi/ 2016-10-25T10:58:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/herpers-zoster-il-vaccino-shingrix-gsk-arriva-alla-fda/ 2020-11-10T08:39:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-perche-il-lancio-di-inflectra-pfizer-negli-usa-cambiera-il-mercato/ 2016-10-25T17:56:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/st-jude-nuovo-report-lancia-allarme-cyber-attack-per-tutti-i-device/ 2016-10-25T14:59:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/payback-farmindustria-aziende-pagano-inefficienze-delle-regioni/ 2016-10-26T09:06:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-codacons-annuncia-class-action-scaccabarozzi-la-scienza-smentira/ 2016-10-26T09:27:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-rimanda-ancora-cessione-quote-roche/ 2016-10-26T11:24:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-per-keytruda-futuro-anche-nelle-combo-attivi-oltre-360-studi-clinici/ 2016-10-26T17:59:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-male-il-q3-ma-gli-analisti-hanno-fiducia/ 2016-10-26T15:28:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/i-farmaci-nella-manovra-finanziaria-tutte-le-novita/ 2016-10-26T16:52:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/agenas-incontra-responsabili-trasparenza-aziende-sanitarie-italiane/ 2016-10-27T09:00:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/herpes-zoster-il-primo-vaccino-sanofi-pasteur-msd-compie-10-anni/ 2016-10-27T16:05:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-i-vaccini-portano-in-alto-il-q3/ 2016-10-27T16:12:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/adhd-da-fda-primo-ok-al-generico-mylan/ 2020-11-10T08:39:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-e-ibm-insieme-per-la-serendipity-industriale/ 2016-10-27T16:26:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-a-milano-lorenzin-e-il-momento-della-diplomazia/ 2016-10-27T17:03:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-del-pacreas-ema-autorizza-formulazione-pegilata-di-shire/ 2020-11-10T08:39:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/centrali-di-acquisto-pubbliche-gutgeld-linee-guida-in-legge-di-stabilita/ 2016-10-28T09:03:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/payback-boggio-assobiomedica-morte-certa-per-le-piccole-imprese-fuga-per-le-grandi/ 2016-10-28T09:16:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fluttuazioni-dei-tassi-dinteresse-e-prezzi-alti-lanno-nero-delle-fusioni-nel-pharma/ 2016-10-28T15:02:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-q3-stellare-ma-preoccupa-laccordo-con-monsanto/ 2016-10-28T11:19:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zika-dopo-usa-sanofi-si-accorda-con-il-brasile-per-sviluppare-il-vaccino/ 2016-10-28T12:14:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-barra-dritta-sulle-malattie-neurodegenerative/ 2020-11-10T08:39:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-cadono-due-candidati-di-fase-avanzata-su-bpco-e-hiv/ 2020-11-10T08:39:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antitumorali-roche-cede-candidato-a-novogen-che-fa-shopping-di-piccole-biotech/ 2020-11-10T08:39:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-gastro-esofageo-astellas-mette-sul-piatto-2-mld-di-dollari-per-candidato-biotech/ 2020-11-10T08:38:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-q3-le-buone-notizie-arrivano-dagli-anti-hiv/ 2020-11-10T08:38:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shire-lematologia-scende-del-6-ma-il-ceo-crede-nel-business/ 2020-11-10T08:38:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-q3-allinsegna-di-imbruvica/ 2020-11-10T08:38:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/esclusivo-merck-kgaa-cerca-acquirenti-per-ramo-biosimilari/ 2016-11-03T13:38:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-volano-i-farmaci-per-le-malattie-rare-delude-il-vaccino-anti-dengue/ 2020-11-10T08:38:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-al-seno-da-fda-revisione-prioritaria-per-ribociclib-novartis/ 2020-11-10T08:38:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-si-riduce-il-forecast-2016-il-ceo-colpa-mia/ 2020-11-10T08:38:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-erik-lommerde-nuovo-corporate-vice-president-europe-south/ 2016-11-03T14:07:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-allarme-tories-a-rischio-laccesso-ai-farmaci/ 2016-11-03T16:44:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-cuba-prove-tecniche-di-collaborazione-sui-vaccini/ 2016-11-03T16:18:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-salvavita-binetti-no-a-speculazioni/ 2016-11-04T18:04:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nutrizione-parenterale-600-pazienti-vivono-grazie-a-uno-zaino-magico/ 2016-11-04T10:30:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valeant-ancora-voci-di-dismissioni-a-takeda-la-bu-gastrointestinale/ 2020-11-10T08:38:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aca-e-prezzi-dei-farmaci-il-day-after-del-voto-usa-per-big-pharma/ 2016-11-04T14:43:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-bene-il-q3-e-caccia-al-nuovo-ceo/ 2020-11-10T08:38:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/binetti-no-a-chi-specula-su-farmaci-salvavita/ 2016-11-04T16:46:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-ritirati-alcuni-lotti-di-novalgina-per-variazione-periodo-di-validita/ 2016-11-04T18:03:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-aifa-80-foglietti-illustrativi-italiani-non-e-piu-bugiardino/ 2016-11-07T17:59:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/meningite-finocchiaro-gsk-con-vaccino-3-milioni-di-morti-in-meno/ 2016-11-07T16:30:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-il-q3-cresce-del-20-grazie-ai-vaccini/ 2016-11-07T16:20:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brilinta-astrazeneca-ok-dal-nice-per-uso-prolungato/ 2020-11-10T08:38:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nash-gilead-punta-forte-sul-proprio-candidato/ 2020-11-10T08:38:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alzheimer-merck-apre-la-strada-degli-inibitori-bace1/ 2020-11-10T08:38:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/melanoma-roche-in-campo-con-cocktail-farmaci/ 2020-11-10T08:38:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/wearable-technology-takeda-verso-lobiettivo-dei-biomarker-digitali/ 2016-11-08T18:10:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/luciano-frattini-nuovo-ad-di-bellco-gruppo-medtronic/ 2016-11-08T15:02:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-italia-michele-perrino-e-il-nuovo-ad/ 2016-11-08T14:12:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/data-collection-e-follow-up-cosi-big-pharma-vincera-la-battaglia-dei-prezzi/ 2016-11-08T18:30:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nice-dopo-4-anni-ok-a-halaven-eisai-contro-il-cancro-al-seno/ 2020-11-10T08:38:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-venerdi-presentazione-nuovo-algoritmo-appropriatezza-osteoporosi/ 2016-11-09T14:32:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-presidente-vincera-anche-big-pharma/ 2016-11-09T14:07:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/parlamento-europeo-aggiornare-regolamento-sui-farmaci-pediatrici/ 2016-11-09T14:16:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lancet-un-dollaro-a-testa-per-garantire-accesso-universale-a-farmaci-essenziali/ 2016-11-09T17:05:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-mylan-punta-al-mercato-globale-con-copia-trastuzumab/ 2020-11-10T08:38:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valeant-crollo-in-borsa-e-profit-warning-dopo-il-q3/ 2016-11-09T15:26:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antitumorali-nuova-generazione-boeringher-ingelheim-finanzia-biotech-svizzera/ 2020-11-10T08:38:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/in-arrivo-nuovi-farmaci-anti-alzheimer-lorenzin-siamo-gia-al-lavoro/ 2016-11-10T09:36:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-antitumorali-effetti-limitati-sulla-sopravvivenza/ 2016-11-10T09:46:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-possibile-riduzione-prezzo-farmaci-per-sclerosi-multipla/ 2020-11-10T08:38:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-vaccino-johnson-johnson-piu-il-booster-immunitario-di-gilead-sembrano-essere-promettenti-per-combattere-lhiv/ 2020-11-10T08:38:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-passati-i-timori-di-manovre-dure-su-costo-farmaci-salgono-azioni-biotech/ 2016-11-10T15:32:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antitumorali-combo-opdivo-bms-candidato-infinity-per-tumori-testa-e-collo/ 2020-11-10T08:38:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-tutte-le-novita-del-2017/ 2016-11-11T17:36:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ue-ok-a-ibrance-pfizer-e-novartis-prepara-il-farmaco-rivale/ 2020-11-10T08:38:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-messo-a-punto-test-che-utilizza-chiave-usb/ 2016-11-11T13:50:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-effetto-trump-anche-per-i-merger/ 2016-11-11T14:52:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-parere-positivo-chmp-per-approvazione-suliqua-sanofi/ 2020-11-10T08:38:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-q3-deludente-per-aree-diabete-e-vie-respiratorie/ 2020-11-10T08:38:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-ecco-il-nuovo-algoritmo-per-appropriatezza-prescrittiva-osteoporosi/ 2016-11-11T16:57:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ssn-nuovi-lea-e-nomenclatore-tariffario-entro-dicembre/ 2016-11-14T18:07:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hcv-bene-il-trattamento-pangenotipico-breaktrough-therapy-di-abbvie/ 2020-11-10T08:35:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/non-solo-italia-ema-fa-gola-a-mezza-europa/ 2016-11-14T18:06:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-fa-marcia-indietro-niente-revisione-anticipata-per-durvalumab/ 2020-11-10T08:35:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/access-to-medicine-index-2016-gsk-al-vertice-per-la-quinta-volta-consecutiva/ 2016-11-14T14:49:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-vende-la-bu-consumer-health/ 2016-11-14T14:55:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-accordo-acticor-biotech-mediolanum-farmaceutici-per-sviluppo-antitrombotico/ 2020-11-10T08:35:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-toujeo-sanofi-superiore-a-insulina-degludec-in-studio-di-confronto/ 2020-11-10T08:35:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-in-italia-incide-per-12-miliardi-di-euro/ 2016-11-15T11:19:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumori-philips-investe-nelloncologia-molecolare/ 2016-11-15T16:46:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-ok-da-fda-per-defibrillatore-personalizzabile/ 2016-11-15T12:33:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medici-sempre-piu-sui-motori-di-ricerca-i-piu-attivi-sono-gli-oncologi/ 2016-11-15T18:50:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-da-fda-procedura-fast-track-per-candidato-contro-la-leucemia/ 2020-11-10T08:35:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epatite-c-zepatier-msd-sempre-piu-efficace-e-tollerabile/ 2020-11-10T08:35:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/accessibilita-ai-farmaci-ecco-le-aziende-top/ 2016-11-15T18:55:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-arriva-in-italia-il-biosimilare-di-etanercept/ 2020-11-10T08:35:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/in-asia-la-cosmetica-e-sempre-piu-italiana-export-a-oltre-700-mln-di-euro/ 2016-11-16T10:05:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/generici-novartis-vuole-rafforzare-sandoz-con-unacquisizione/ 2016-11-16T11:23:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cardiopatie-mayo-clinic-e-biotech-usa-scoprono-i-biomarcatori-vocali/ 2016-11-16T18:58:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/accordo-abbott-st-jude-medical-sotto-la-lente-dellantitrust-ue/ 2016-11-16T14:32:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dengue-un-mercato-da-1-mld-di-dollari-tra-sanofi-e-takeda/ 2016-11-16T18:21:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-ibm-watson-esaminera-10-genomi-di-tumori-resistenti/ 2016-11-16T16:47:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricetta-dematerializzata-in-testa-la-campania-bolzano-la-provincia-meno-virtuosa/ 2016-11-17T10:17:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-ospedalieri-tar-respinge-ricorso-roche-contro-regione-piemonte/ 2016-11-17T10:27:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lorenzin-prezzi-farmaci-epatite-c-ancora-inaccettabili/ 2016-11-17T10:53:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/leo-pharma-italia-quando-la-dermatologia-e-millennial/ 2016-11-17T16:41:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-rasi-per-ema-temo-perdita-leadership-scientifica/ 2016-11-17T18:56:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/artrite-psoriasica-testa-a-testa-fra-celgene-e-novartis-con-pfizer-alla-finestra/ 2020-11-10T08:35:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sarcoma-tessuti-molli-da-ce-ok-a-olaratumab-eli-lilly/ 2020-11-10T08:35:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-da-conferenza-stato-regioni-via-libera-a-melazzini-direttore-generale/ 2016-11-17T18:54:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-a-milano-il-governo-stanzia-56-milioni-di-euro/ 2016-11-18T10:14:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/acquisizioni-divisione-farma-bracco-entra-nel-gruppo-dompe/ 2020-11-10T08:35:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-q3-mediocre-ma-incassa-la-fiducia-degli-analisti/ 2016-11-18T18:01:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapia-del-dolore-grunenthal-acquista-thar-per-ampliare-la-pipeline/ 2016-11-18T18:09:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/artrite-reumatoide-parte-la-survey-per-indagare-limpatto-nella-vita-dei-pazienti/ 2016-11-18T14:07:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-riuscira-trump-a-risollevare-la-reputazione-di-big-pharma/ 2016-11-18T17:47:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-da-hpv-al-via-sperimentazione-combo-keytruda-vaccino-genexine/ 2020-11-10T08:35:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-viiv-healthcare-gsk-lancia-due-studi-per-terapia-iniettabile-a-lunga-durata/ 2020-11-10T08:35:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanita-digitale-italia-in-zona-retrocessione-nella-classifica-europea/ 2016-11-21T13:14:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/radiologia-il-gruppo-multimedica-va-sul-cloud/ 2016-11-21T11:20:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/da-farmaco-a-blockbuster-ecco-come-si-fa/ 2016-11-21T17:01:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattia-di-chron-via-libera-da-ce-per-ustekinumab-janssen/ 2020-11-10T08:35:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipercolesterolemia-ancora-non-e-tempo-di-praluent-sanofi-e-regeneron/ 2020-11-10T08:35:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/asma-chiesi-acquista-portfolio-di-atopix-therapeutics/ 2016-11-21T14:16:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-innovativi-in-italia-tra-lancio-e-accesso-passano-oltre-14-mesi/ 2016-11-21T17:05:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-antitrust-in-legge-bilancio-limiti-alla-concorrenza/ 2016-11-21T17:35:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-a-milano-maroni-la-farmaceutica-non-entri-nel-dibattito/ 2016-11-22T09:53:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-medici-e-pazienti-contro-la-determina-458/ 2016-11-22T10:00:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-allesame-fda-pompa-impiantabile-a-rilascio-antagonista-glp-1/ 2016-11-22T18:28:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bpco-combo-gsk-alla-fda-con-18-mesi-di-anticipo/ 2020-11-10T08:35:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antitumorali-celgene-e-triphase-insieme-per-farmaco-contro-glioblastoma/ 2020-11-10T08:35:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-marshall-abbandona-litalia-e-vende-green-hill/ 2016-11-22T13:31:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/designazioni-di-breakthrough-therapy-valore-reale/ 2020-11-10T08:35:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/varicella-solo-9-italiani-su-100-sanno-che-esiste-il-vaccino/ 2016-11-22T17:51:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-in-10-anni-raddoppiate-le-approvazioni-di-farmaci-pediatrici/ 2016-11-23T10:12:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-la-mancata-aderenza-costa-al-mondo-637-miliardi-di-dollari/ 2016-11-23T16:28:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alzheimer-solanezumab-eli-lilly-non-raggiunge-lendpoint-primario-studio-clinico-fase-iii/ 2020-11-10T08:35:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-melazzini-vaccini-sicuri-come-tutti-i-medicinali/ 2016-11-23T14:05:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anemia-falciforme-665-mln-di-dollari-da-novartis-per-candidato-biotech-americana/ 2020-11-10T08:35:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/glaucoma-via-libera-da-fda-per-shunt-allergan/ 2016-11-23T15:40:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-testa-a-testa-fra-le-combo-di-sanofi-e-novo-nordisk/ 2020-11-10T08:35:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-anche-lfda-dice-si-a-soliqua-sanofi/ 2020-11-10T08:34:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/determina-458-sifo-aifa-definisca-criteri-per-equivalenza-terapeutica/ 2016-11-23T17:58:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/leuropa-dei-sistemi-sanitari-bene-litalia-ma-la-crisi-morde-ancora/ 2016-11-24T10:27:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/melazzini-aifa-ruolo-farmacologici-essenziale-per-la-ricerca/ 2016-11-24T17:34:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-antitumorali-un-mercato-da-75-miliardi-di-dollari-entro-il-2022/ 2016-11-24T13:20:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antibiotico-resistenza-zoetis-a-fianco-dei-veterinari/ 2016-11-24T14:13:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-la-cina-e-sempre-piu-vicina/ 2016-11-24T14:47:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shire-in-usa-nasce-campus-multidisciplinare-per-malattie-rare/ 2020-11-10T08:34:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zika-esercito-usa-testa-vaccino-sugli-umani/ 2020-11-10T08:34:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-italia-marco-ercolani-alla-guida-della-nuova-bu-vaccini/ 2016-11-25T17:54:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/premio-le-fonti-e-di-takeda-italia-il-digital-team-del-2016/ 2016-11-25T10:32:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mieloma-multiplo-aifa-approva-rimborsabilita-per-revlimid-celgene/ 2020-11-10T08:34:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-del-polmone-e-impatto-sociale-nasce-il-roche-lung-cancer-observatory/ 2016-11-25T13:10:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/linfoma-di-hodgkin-commissione-europea-approva-nivolumab-bms/ 2020-11-10T08:34:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abiogen-allad-di-martino-il-premio-imprenditore-dellanno-2016/ 2016-11-25T17:44:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/artrite-reumatoide-nuove-conferme-per-baricitinib-eli-lilly/ 2020-11-10T08:34:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-oltre-a-quelli-di-sanofi-e-gsk-ci-sara-un-vaccino-australiano/ 2020-11-10T08:34:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ad-alberto-chiesi-laurea-honoris-causa-dalluniversita-di-parma/ 2016-11-28T10:26:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattia-di-chron-al-via-fase-iii-di-filgotinib-gilead-obiettivo-2019-sul-mercato/ 2020-11-10T08:34:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-nuovo-shopping-una-combo-per-lalzheimer/ 2016-11-28T13:24:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-la-cina-guarda-a-cambridge-e-investe-negli-anticorpi-sperimentali/ 2016-11-28T17:50:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mieloma-multiplo-commissione-europea-autorizza-ninlaro-takeda/ 2020-11-10T08:34:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-compra-in-svizzera/ 2020-11-10T08:34:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-rare-a-sergio-dompe-il-premio-armr-2016/ 2016-11-28T14:36:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/herpes-zoster-il-vaccino-shingrix-gsk-al-vaglio-dellema/ 2020-11-10T08:34:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/manovra-fondi-per-i-farmaci-innovativi-biosimilari-no-alla-sostituibilita-automatica/ 2016-11-29T18:15:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tar-lazio-abbvie-puo-accedere-a-documentazione-accordo-gilead-aifa-su-harvoni/ 2016-11-29T15:09:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chi-spende-di-piu-nel-marketing-digitale-big-pharma-cina/ 2016-11-29T18:33:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-oncologici-menarini-fa-shopping-in-giappone/ 2020-11-10T08:34:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-per-la-metformina-un-futuro-da-antitumorale/ 2020-11-10T08:34:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-da-banco-e-senza-ricetta-il-punto-a-10-anni-dalla-liberalizzazione/ 2016-11-29T17:52:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scaccabarozzi-farmindustria-nel-mondo-850-molecole-studiate-per-le-donne/ 2016-11-30T18:21:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/accesso-ai-farmaci-accordo-novartis-ruanda-per-malattie-non-trasmissibili/ 2016-11-30T10:19:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-lo-switching-di-truvada-gilead-vale-300-mln-di-dollari/ 2020-11-10T08:34:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dolore-marchio-ce-a-dispositivo-nato-da-campagna-di-crowfunding/ 2016-11-30T18:25:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-in-europa-a-rischio-obiettivo-2030-di-eradicazione/ 2016-11-30T17:58:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malaria-nel-2018-prima-campagna-di-vaccinazione-oms-con-vaccino-gsk/ 2016-11-30T17:55:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-4-mld-di-dollari-per-fusioni-e-acquisizioni/ 2016-12-01T11:47:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-apple-in-campo-per-obiettivo-2020-unaids/ 2016-12-01T14:05:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuovi-antibiotici-750-mln-di-dollari-da-sanofi-per-candidato-biotech-americana/ 2016-12-01T14:05:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/focus-reumatologia-lindustria-si-racconta/ 2016-12-01T17:48:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/actelion-no-a-26-mld-di-dollari-da-jj/ 2020-11-10T08:34:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diagnostica-general-electric-e-ospedale-pediatrico-di-boston-per-immagini-sul-cloud/ 2016-12-01T14:56:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-menarini-in-italia-250-assunzioni-nel-2016/ 2016-12-02T17:44:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boggio-assobiomedica-in-italia-6-400-apparecchiature-obsolescenti/ 2016-12-02T12:06:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/acquisizioni-salta-accordo-takeda-valeant-per-salix/ 2016-12-02T13:15:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibm-parte-il-progetto-watson-for-drug-discovery/ 2016-12-02T13:48:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-camera-rappresentanti-approva-la-legge-21st-century-cures/ 2016-12-02T17:45:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-farmaco-takeda-per-colite-ulcerosa-induce-remissione-su-modello-animale/ 2016-12-02T16:31:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-discute-delle-possibili-modifiche-sotto-lamministrazione-trump/ 2016-12-05T18:07:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-consente-a-lilly-di-citare-i-dati-cardiaci-di-jardiance-azioni-salto/ 2020-11-10T08:34:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumori-del-sangue-allincontro-della-ash-nuovi-dati-su-farmaci-abbvie/ 2020-11-10T08:34:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nice-da-lok-a-keytruda-di-merck-per-il-cancro-al-polmone/ 2020-11-10T08:34:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-del-seno-buoni-tassi-di-risposta-del-biosimilare-di-trastuzumab/ 2020-11-10T08:34:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/leucemia-mieloide-cronica-bosulif-pfizer-efficace-su-pazienti-mai-trattati/ 2020-11-10T08:34:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/con-farmacisti-in-corsia-migliorano-lassistenza-e-i-costi/ 2016-12-06T10:04:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/welfare-aziendale-abbvie-al-via-flexible-benefit-e-programmi-salute-per-i-dipendenti/ 2016-12-06T15:13:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/leparina-non-previene-coaguli-a-gambe-e-polmoni-dopo-artroscopia-e-ingessatura/ 2020-11-10T08:34:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spesa-globale-per-farmaci-da-prescrizione-nel-2021-arrivera-a-15-trilioni-di-dollari/ 2016-12-06T15:13:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-gran-bretagna-verso-la-sugar-tax/ 2016-12-06T14:50:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-politica-fiscale-di-trump-potrebbe-stimolare-il-ma-farmaceutico/ 2016-12-06T15:15:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/defibrillatori-difettosi-st-jude-medical-in-toscana-controlli-in-corso/ 2016-12-07T12:01:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-del-polmone-limmuno-oncologia-come-terapia-di-prima-linea/ 2020-11-10T08:34:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gene-editing-contenzioso-davanti-allagenzia-di-brevetti-americana/ 2016-12-07T13:24:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/elysium-per-pillola-anti-aging-raccolti-finanziamenti-da-20-milioni/ 2020-11-10T08:34:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-transatlantic-awards-2016-va-a-medtronic-per-gli-investimenti-nel-polo-di-mirandola/ 2016-12-07T16:53:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-al-vertice-dellfda-un-ultraliberista/ 2016-12-12T16:19:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-con-nuove-linee-guida-jardiance-eli-lilly-al-top/ 2016-12-12T12:47:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alzheimer-presto-un-videogioco-diagnostico-firmato-pfizer/ 2016-12-12T13:09:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-al-seno-celgene-vira-sulla-combo-abraxane-immunoncologici-per-il-triplo-negativo/ 2020-11-10T08:34:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/stent-coronarici-al-via-prima-gara-nazionale-consip/ 2016-12-12T18:16:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ecco-il-nuovo-governo-lorenzin-confermata-alla-salute/ 2016-12-12T18:12:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-arriva-in-usa-il-generico-di-tamiflu-roche/ 2020-11-10T08:34:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/digital-health-crowdfunding-per-penna-insulinica-bluetooth/ 2016-12-13T14:13:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-arriva-lo-tsunami-biosimilari-per-la-top-ten-2017/ 2020-11-10T08:34:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-copertura-sanitaria-universale-ancora-lontana/ 2016-12-13T15:00:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/patologie-polmonari-accordo-di-collaborazione-mediolanum-farmaceutici-apeptico/ 2020-11-10T08:34:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-investe-in-canda-e-nasce-bluerock-therapeutics/ 2016-12-13T18:14:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/italia-hub-europeo-della-ricerca-tutti-dicono-di-si/ 2016-12-13T17:45:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/omeopatici-da-aifa-linea-guida-per-eccipienti-su-etichetta-e-foglio-illustrativo/ 2016-12-13T17:58:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scaccabarozzi-farmindustria-farmaceutica-traina-crescita-paese/ 2016-12-14T14:17:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-anti-cancro-anche-pfizer-punta-alla-combo-con-immuno-oncologici/ 2020-11-10T08:34:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipercolesterolemia-larrivo-dei-generici-spariglia-mercato-usa/ 2020-11-10T08:33:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/intelligenze-artificiali-wfo-ibm-sempre-piu-preciso-nei-tumori-del-seno/ 2016-12-14T15:35:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/actelion-per-lacquisizione-lascia-jj-e-spunta-sanofi/ 2016-12-14T15:32:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-bms-rivoluziona-la-geografia-dei-propri-impianti-negli-usa/ 2016-12-14T15:49:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boggio-assobiomedica-da-nuovo-governo-riforme-e-impegno-in-ricerca-e-innovaziine/ 2016-12-14T18:02:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuovi-lea-lorenzin-risultato-eccezionale/ 2016-12-15T11:45:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spesa-sanitaria-quella-italiana-e-la-piu-bassa-nelleuropa-occidentale/ 2016-12-15T17:46:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/colangite-biliare-ema-approva-ocaliva-intercept/ 2020-11-10T08:33:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/csr-roche-italia-lancia-il-conto-welfare-per-i-propri-dipendenti/ 2016-12-15T13:34:04+00:00 monthly 0.2